[
  {
    "instruction": "Analyze the molecule CC(O)(P(=O)(O)O)P(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)OOC(C)(C)CCC(C)(C)OOC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@@H](O)[C@H](O)[C@@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COC(=O)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCOC(=O)C(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCOCC(O)CN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)CC(C)(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)CC(C)(C)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNC(=S)NCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNC(=O)NCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCC(=O)OC(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CCC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCCNCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC(=O)NCCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCOC(=O)CCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(COC(=O)CCS)(COC(=O)CCS)COC(=O)CCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule F[B-](F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C/C=C/C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[Si](C)(C)N[Si](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)/C=C(\\CC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CO)[C@@H](O)[C@H](O)[C@@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[Si](OC)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCNCCNCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCNCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NCC(=O)CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCOCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)CNCC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cu][I] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)COCC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[Si](C)(C)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCOS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(Cl)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCOC(=O)C=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[P+](CCCC)(CCCC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCNC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(CCC)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C[P+](C)(CC(C)C)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC[P+](CCCCCCCC)(CCCCCCCC)CCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(OC(CCl)CCl)(OC(CCl)CCl)OC(CCl)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CNCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=S)NNC(N)=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=S)C(N)=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [CH3][Hg][Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [Hg+2] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-AhR, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCNC(=N)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCCC)C(=S)SSC(=S)N(CCCC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)/C=C(\\C)OP(=O)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=CC(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [O]=[Cr](=[O])([OH])[O][Cr](=[O])(=[O])[OH] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(N)CN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)CN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@@H](N)CCCN/C(N)=N/[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[O][Cr]([O]C(C)=O)[O]C(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCNC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)[C@@H](S)[C@H](S)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCS)OCC(COC(=O)CCS)(COC(=O)CCS)COC(=O)CCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(N)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])C(CO)(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(CO)(CO)COCC(CO)(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])OCCN(CCO[N+](=O)[O-])CCO[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(CO)(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[Si](CCCS)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)=CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [O]=[Zr]([Cl])[Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=N)NC(=N)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[CH2][Sn]([CH2]CCC)([O]C(C)=O)[O]C(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC[C@H](C)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(O)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCOP(=O)(O)OCCOC(=O)C(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OS(C)(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)C#CC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCC)C(=O)SCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cl)(Cl)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCl)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C/C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCNCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCNCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(CC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)CCCCC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)ON=CC(C)(C)SC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)NN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCCOCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CSCCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C/C=C/C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC=CCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(O)CCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)NC(O)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC/C=C/C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CC/C=C/C(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOCCSC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCOS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CC=O)CCCC(C)(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COC(=O)CCCCC(=O)OCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)NC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [O-][Cl+3]([O-])([O-])O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(C)N=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCC)N=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[N+](CCCC)(CCCC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(=O)OC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCSSCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCCCCCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Ba+2] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CP(=O)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)COCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC(C#N)=C(C#N)C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)CC(=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)NCNC(=O)C=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CSCSC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC[P+](CCCC)(CCCC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[S+](C)CCC(N)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC[C@@H](O)C/C=C\\CCCCCCCC(=O)OCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC(=O)OCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC(=O)OCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCN(CC=C)C(=O)C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC[C@@H](O)C/C=C\\CCCCCCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[CH2][Sn]([Br])([CH2]C)[CH2]C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(CO)(CO)COCC(CC)(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCCCOC(=O)C(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC(=O)N(CC)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCCOCCOCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCN(C)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCCOCCOCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. MODERATE-RISK: 17 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NNCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)SCSCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)N(CCO)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)=NO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(O)C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC#CC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC/C=C/C(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC(=O)OCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C/C=C/CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCOS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(CO)[C@@H](O)C(=O)NCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C(\\C)C(=O)OC/C=C(\\C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCOC(=O)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCC(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(C)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=CC=CCOC(=O)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CCOC(C)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C(Cl)C(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCC[C@H](N)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCCCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCOS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=O)(OC)OC=C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cl)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCNCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][Pd][Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC=CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C/CCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)CCCS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [TlH3] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCCCCCCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OP(C)(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COS(=O)(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)CNC(=O)CC(C)OC(=O)CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)NC(CCC(N)=O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(CN)CC(C)CCNCC(O)CNCC(C)CC(CC)CN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(O)OC(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOCC(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(Cl)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC(CCl)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][Ba][Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CC(O)(CC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNP(=S)(OC)O/C(C)=C/C(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCCC(C)=CC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CCSCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[Si](C)(OC(C)=O)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Br)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(CCl)C(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)NC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=COCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COP(=O)(OCC(C)C)OCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(CO)COC(=O)C(C)(C)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)N=NC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)=C(Cl)C(Cl)=C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)/C=C\\C(=O)OCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)C#CC(C)(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CNCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCC(=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)(Cl)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN=C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Na][I] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[N+](C)(CCCC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CNNC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNC(=S)NCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)/C=C\\C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(C=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(OCC)OP(=O)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CF for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCC(C)OCC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCOCC(CC)(COCCOC(=O)C=C)COCCOC(=O)C=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCCCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cl/C=C/Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cl/C=C\\Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(Cl)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)CC(CC(=O)OCCCC)(OC(C)=O)C(=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)OCCC(C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](CCC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)OC/C=C(\\C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CP(=O)(O)OCCC[Si](O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)C(C)OC(=O)CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C=C(C)CCC=C(C)C)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[Si](OC(=C)C)(OC(=C)C)OC(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(=O)CCCCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCON=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NC)CC(=O)O)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [O]=[Mo](=[O])=[O] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(S)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COP(=O)(O)OCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)CCCCC(=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [O]=[Cr][O][Cr]=[O] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cr+3] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC(=O)OCC(C)OC(=O)CCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOCCOCCOC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(S(=O)(=O)CC)S(=O)(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](O)[C@H](N)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC(=O)NCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC#CC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=S)S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(OCCCOC)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [CH3][Sn]([CH3])([Cl])[Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)C(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CC(C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C)(C)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Fe+2] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(CO)[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC[N+](C)(C)CCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCC(=O)OCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(N)=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCI for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCC=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCSC(=O)N(CCC)CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(OCC(Br)CBr)(OCC(Br)CBr)OCC(Br)CBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)(Br)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)COC(=O)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=CC(=O)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CSCCCN=C=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCNCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(CCC)C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCC/C=C\\C=C/C=C\\C=C/C=C\\C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[CH2][Sn]([Cl])([Cl])[Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOCC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(CO)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(S)C(=O)N[C@@H](CS)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)CCCCCCCC(=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOC(=O)CCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCSSCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCNC(N)=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(O)C(C)(C)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][Nd]([Cl])[Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCOC(=O)CCCCC(=O)OCCCCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCCC(C)CC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Co+2] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC(=O)OCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=S)S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ATAD5, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C#N)C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(Br)C(=O)NC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCC(C)NCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C(Cl)C(=O)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NC(=O)NC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCC(Br)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCCCCCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)CC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCCC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=NN(CCCl)C(=O)NCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[Si](OCC)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(C)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCSCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C/C(Cl)=C(/Cl)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde, 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOP(=O)(OCCCC)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(CCC(C)C)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCSSCC=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)[O][Sn]([CH2]CCC)([CH2]CCC)[CH2]CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCC(C)(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC/C=C/C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][Yb]([Cl])[Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCCCCCOC(=O)C=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(C)CC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [PbH4] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)N(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCC[Si](OC)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(S)CS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)C(Cl)=C(C)OP(=O)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)CCCCC(=O)OCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNP(N)(N)=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)CCC(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@@H](O)[C@@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](CS)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)CCCC(C)(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(CS)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[Si](CCCNC(N)=O)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCOC(=O)CCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOC(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CCOC(=O)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+](C)(CC)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCCN(CCCl)CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC/C(O)=N\\C(CO)CCCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)NO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Fe+3] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS/C(C)=N/OC(=O)N(C)SN(C)C(=O)O/N=C(\\C)SC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OB(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)[C@H](O)[C@@H](O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)CCCCC(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CC(O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCC[Si](Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCCCCCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)NC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cu+2] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CCCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCC(Cl)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCN(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCC=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[CH2][Sn]([CH2]CCC)([CH2]CCC)[CH2]CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][In]([Cl])[Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(C)(C)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [As]#[In] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOC(=O)CC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCCN(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCCCC(C#N)CCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)CC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FCOC(C(F)(F)F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 7 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 12 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC/C=C\\C/C=C\\CCCCCCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[Si](OC(C)=O)(OC(C)=O)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOCCOC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNC(=O)OCC#CI for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ATAD5, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)NNC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)/C=C/C=C(C)/C=C/C=C(C)/C=C/C=C(C)/C=C/C=C(C)\\C=C/C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCCCCCCCOCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC/C=C/C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCCOCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCC(=O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule S=C(S)NCCNC(=S)S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]([O-])(CCCl)CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. MODERATE-RISK: 22 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)[O][Sn]([CH2]CCC)([CH2]CCC)[CH2]CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOCCOCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CC(C)(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(O)CN(CP(=O)(O)O)CP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCNCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC[N+](CCCCCCCC)(CCCCCCCC)CCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(Cl)C(F)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrC(Br)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C/CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=O)(NC(C)=O)SC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C)(C)CCCC(C)CC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClP(Cl)(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(Cl)CC(Cl)C(Cl)C(Cl)C(Cl)C(C)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[Si](C)(C)O[Si](C)(C)C=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C)(COC(N)=O)COC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CO)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)OC(=O)CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC/C(C)=C\\CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(O)CCCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)/C=C\\C(=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC/C(C)=C/CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCCC(C)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC[N+](C)(C)CCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCON=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(CBr)(CBr)CBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(Cl)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(Cl)(Cl)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(CCC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCCCCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C[C@@H](O)[C@H](O)[C@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CC(=O)C=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(CCC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CCC=C(C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(CC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=COCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCOCCOCCOC(=O)C(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C#N)C(C)(C)C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CSSC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cl)(Cl)[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])C(Br)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)C(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CCC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCNCCSP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=S)NN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=N\\O)/C(C)=N/O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N[C@@H](C=O)[C@H](O)[C@H](O)[C@@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. MODERATE-RISK: reactive aldehyde. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOCCOCCOCCOC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[Si](C)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC[Si](OCC)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)NC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCSCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[CH2][Sn]([Cl])([Cl])[CH2]CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase, NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[Si](OC)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C#N)/N=N/C(C)(C#N)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(S)C(=O)NCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cd+2] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ATAD5, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCN(CC#N)CCN(CC#N)CC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)C(CO)C(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOCCOCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CC(=O)Cl)CC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CCCCCCCCCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C/C/C=C/C/C=C/CCCCCCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)CC(O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)NCCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCC(CC)(COC(=O)C(=C)C)COC(=O)C(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCC(CCCCCC)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CN)CC(C)(C)CCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(C)(N)C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=S)S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COC(=O)CC(C(=O)OCC(C)C)S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [SnH4] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCOCCOS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)O/N=C/C(C)(C)S(C)(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(Cl)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)CCCCCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CCCCCCCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[Se](O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CCCCCCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=S)S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCCC)C(=S)S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(CO)[C@@H](O)C(=O)NCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)CC(=O)C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C=CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCNCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)NCCCS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC=NO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(=N\\O)[C@@H](C)NCC(C)(C)CN[C@H](C)/C(C)=N/O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[S+](C)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][Au]([Cl])[Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCNCCNCCNCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCOCCOCCOCCOC(=O)C=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[Si](CC)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CN(CC(=O)O)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCCC(Br)(C#N)CBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(OCC)SCCSCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD) and cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC(=O)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CCO)CCCC(C)(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCOCCOCCOCCOC(=O)C(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC/C=C\\C=C\\C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C/CCCCCCCCCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C/C/C=C\\CCCCCCCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C/C=C/CCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCCCOC(=O)C=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCI for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)C(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)CN(CCN(CC(C)O)CC(C)O)CC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C#N)/N=N/C(C)(C)C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[Se]CC[C@H](N)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)N(C)C(=O)CSP(=S)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CC/C=C/CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)CCC[C@H](C)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C)C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=S)SC(=S)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ATAD5, SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=S)SSC(=S)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-ATAD5, SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[P+](CO)(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])C([N+](=O)[O-])([N+](=O)[O-])[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(CC)CCCCCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOS(C)(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=O)(O)OP(=O)(O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[Si](C)(C)O[Si](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)CC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(Br)=C(Br)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrC/C=C/CBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC(Br)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCC[N+](C)(C)CCC[Si](OC)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C#N)CCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOCC(O)CS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. MODERATE-RISK: 17 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)CCCC(C)(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=O)(O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)NC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][Dy]([Cl])[Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)OCCCCOS(C)(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCSSCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C[C@H](CN)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCC(O)(P(=O)(O)O)P(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCN(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule FB(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)CNCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)N=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)N=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(Cl)CCC(Cl)C(Cl)CC(Cl)C(Cl)C(Cl)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. MODERATE-RISK: 7 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC(O)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[P+](CC)(CCCC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(CCCC(C)C)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC/C(C)=C/C=C\\C(C)=C\\C=C\\C(C)=C\\C=C/C=C(C)/C=C/C=C(C)/C=C\\C=C(/C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(O)C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)=C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCC(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C=NCCCCCCN=C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCSCSCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(C)(O)C#CC(C)(O)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC(=O)[O][Sn]([CH2]CCC)([CH2]CCC)[O]C(=O)CCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[Si](CCCNCCN)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCCC(C)=CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCO[PH](=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)NCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CCI for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. MODERATE-RISK: 14 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C(\\C)C(=O)OCC/C=C\\CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CCOC(=O)CCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCN(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CCO)CC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC[CH2][Sn]([Cl])([Cl])[CH2]CCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(O)CC/C=C(\\C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCSC(=O)N(CC)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCCOCCCOC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC[C@@H](O)C/C=C\\CCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=NO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC(=O)NO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Br)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC(SP(=O)(OC)OC)C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@@H](O)C(O)[C@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)NCCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NNC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCCCCCCCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COS(=O)(=O)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(COCCO)OCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCC(=O)NN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC#CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(Br)CBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic linear or acyclic framework. MODERATE-RISK: 17 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)NC(C)(C)CS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OB(OC(C)C)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCOC(=O)CS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(O)OCC(C)OC(O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)SSS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)C(C)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCC(C)OC(=O)C(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCC(Br)(Br)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule BrC(Br)C(Br)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)OCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)CCCCCCCCC(=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC(=O)N(C)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC/C=C\\CCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(=O)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCSCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(CC(C)CCCC(C)(C)O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(O)CC/C=C(/C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CC(C(C)=O)C(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(O)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC/C=C\\C/C=C\\CCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\C/C=C\\C/C=C\\CCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCSSCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=S)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CSC(C)(C)/C=N\\O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [Br][Ca][Br] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC(CC(=O)OCC)(OC(C)=O)C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. MODERATE-RISK: 13 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[P+](C)(CCCC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CC(O)(/C=C\\Cl)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(O)C(Cl)(Cl)P(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(CC)OC(C)COC(O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCOCCOCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(=O)CC(C)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)C(N)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(C)(C)S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC/C=C(/C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)C(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC/C=C/CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)/C=C(\\C)[O][Ti]([O]/C(C)=C/C(=O)OCC)([O]C(C)C)[O]C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CC(C(=O)O)S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCC(N)(C(=O)O)C(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCC[C@H](O)[C@@H](N)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCSP(=O)(OCC)SCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)OC(Cl)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)OC(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#C/C(N)=C(/N)C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[CH2][Sn]([CH2]CCC)([CH2]CCC)[O][Sn]([CH2]CCC)([CH2]CCC)[CH2]CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CCl)OC(C)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(CO)(CBr)CBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCCOCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN=C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCSCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [P]#[In] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CC(Cl)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C)(COC(N)=O)COC(=O)NC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Mn+2] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CON=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)OC(Cl)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCOCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(=O)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(CC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(=O)OC(=O)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCC(=O)OCC)C(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C=C(C)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCC(C)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N[C@@H](CCC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)C(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=S)NC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC[N+](C)(C)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(N)C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCC=CC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCCOCCOCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)CF for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[O][Ti]([O]CCN(CCO)CCO)([O]CCN(CCO)CCO)[O]C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCSC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)OOC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)CO[PH](=O)OCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)CC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(N)CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC(Br)(Br)C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC/C=C/C=C\\C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCCC(C)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(O)C(O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOP(=O)(O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCO[Si](OCCC)(OCCC)OCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cl)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [O]=[Cd] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(CCC=C(C)C)OC(=O)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)/C=C/C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)COC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule S=C=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CCl)OP(=O)(OC(C)CCl)OC(C)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCCOP(OCCCl)OCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCOCCOC(=O)C=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-ER, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCCOCCOCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)SCCSCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)(Cl)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic linear or acyclic framework. MODERATE-RISK: 17 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. MODERATE-RISK: reactive aldehyde. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)CCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCSCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)COCC(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(O)CS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Be+2] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C(C)=N/O[Si](C)(O/N=C(\\C)CC)O/N=C(\\C)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(CCCCCCCCCCC(=O)OCC(COC(C)=O)OC(C)=O)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(CCC=C(C)C)OC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC/C(C)=C/CC/C(C)=C/CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOC(=O)CCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(Cl)CSC(=S)N(CC)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-ER) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(N)CCCC(C)(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCOCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CC([S][Au])C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=NN(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCCC)N=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CN(CC(C)=O)N=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOP(=O)(OCCOCCCC)OCCOCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC/C=C\\CCCCCCCCCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: reactive aldehyde. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC/C=C/CCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [N-]=[N+]=[N-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCC(=O)CCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)CCC(C)(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCC(C(=O)O)C(O)(CC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)N[C@@H](CCC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ON=CC=NO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC(O)(CC(=O)OCC)C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)SCSP(=S)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(O)CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(OCCCl)(OCCCl)OCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COP(=O)(OCC(CC)CCCC)OCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cl)C(C)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[Si](C)(CCCN)O[Si](C)(C)CCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CN(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N[C@@H](CS)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Zn+2] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOC(=O)/C=C\\C(=O)OCC=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[SiH](C)O[Si](C)(C)O[Si](C)(C)O[SiH](C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(Br)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=CC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)P(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCOCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)NCCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC(C)C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCCCC(=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOC(=O)CCCCCCCC(=O)OCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC[N+](C)(C)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C#N)CCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N[C@@H](CC(C)C)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(O)/C=C/C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)NCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCCCCCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCSCC(COC)COP(=O)([O-])OCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)OC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[Si](OCCOC)(OCCOC)OCCOC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCON=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(N=O)C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCCC(C)CCOC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[Si](CCCS)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CNC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClSC(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC=CC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=CCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [NH2][Pt]([NH2])([Cl])[Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOC(=O)COCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=S)SSC(=S)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC[N+](C)(CCCCCCCCCC)CCC[Si](OC)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCOC(=O)CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)OP(=S)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCCOC(=O)CCCCC(=O)OCCCCCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(O)OCCCOC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)/C=C\\C(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC(C(C)=O)C(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCC(C)(C)COC(=O)C(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[Si](OC)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCN(C)CCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCSCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(N=O)C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC/C=C\\C/C=C\\CCCCCCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) and cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COS(C)(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(N=O)C(=N)N[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CO)(CO)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCOCCOCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O[C@@H]([C@H](O)[C@H](O)CBr)[C@H](O)CBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCN(C)CCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=COCCOCCOC=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCNCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCOCCOCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[Si](C)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)P(=O)(N(C)C)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(O)CCCCCCCCCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOCCOC(=O)CCCCC(=O)OCCOCCOCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=S)S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)ON=C(C)SC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(OCCC)OCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+](CC)(CC)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC(=O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCCCCCOC(=O)C(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)CSP(=S)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrC(Br)C(Br)(Br)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCC(=O)N(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)OCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(N)=[Se] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCCCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOS(=O)(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)CCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(CCC=C(C)C)OC(=O)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)CS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)CCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCOCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OP(=O)(CP(=O)(OC(C)C)OC(C)C)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)NCOCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)N(C)N=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCCS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[Si](CCCCl)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCSCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOC(=O)C(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(Br)CBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[Si](C)(C)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(Cl)C(Cl)C(Cl)CC(Cl)C(Cl)C(C)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCCC(C)CC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCC(C)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCSCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(S)C(C)S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC/C=C/C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CN(CCN(CC(C)OCCO)CC(C)OCCO)CC(C)OCCO)OCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[Se]=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC/C=C\\CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)NC(O)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. MODERATE-RISK: 15 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 13 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(C)C(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCC(Br)CBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(O)CCC=C(C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule IC(I)=C(I)I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(O)OP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)ON=C(CSC)C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCCSCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C(\\C)C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cl)C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CC(C)(O)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(Cl)[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=C)CCCC(C)(C)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(O)CC/C=C(\\C)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(Cl)[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(CCC)(C(=O)OCC)C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CSCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(C)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCC(C)CC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCS(=O)(=O)C(C)(C)S(=O)(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CN(CCOCCOCCN(CC(=O)O)CC(=O)O)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCN=C=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOC(=O)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCSC(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC[N+](C)(C)CC(=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCC(CO)CCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOCC(O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCNCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CCC=C(C)CC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCC(=O)N(C)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCN(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(Cl)=C/CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[Si](CCC#N)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[Si](CCCN)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC/C=C(\\C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCC(C)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NNC(=O)CCCCC(=O)NN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)OOS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCNCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(O)OC(O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[Si](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][Zn][Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCOS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC/C=C/CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)CCC(=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)N(C(=O)SCC(Cl)=C(Cl)Cl)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCCC)CCCCCCN(CCCC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCCCOC(=O)CCCCC(=O)OCCCCCCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC[Si](OCC)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)CO[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=S)NC(N)=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(C)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(O)CCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [CH3][Sn]([Cl])([Cl])[Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C=C(C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)NO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(CCCl)CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)S(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=COC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=O)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(O)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)NCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOC(=O)CCCCCCCCC(=O)OCCOCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCCCCNCCCCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CC(C)C)=NO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[Si](CCCNCCC[Si](OC)(OC)OC)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[Si](OCC)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CNC(=N)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC[N+](C)(C)CCCS(=O)(=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C(=O)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CC)C(=O)SCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][Ni][Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNC(=N)NC(=N)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(Cl)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(Cl)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOC(=O)C(C)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][Sb]([Cl])[Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COCC(C)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)ON=C(SC)C(=O)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC[P+](CCCCCC)(CCCCCC)CCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(CO)(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C)(C)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CO)(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CC[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@H](CO)NCCN[C@@H](CC)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [O]=[Bi][Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCC(=O)OCCOC(=O)CCCCCCC/C=C\\CCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCC(=O)OCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 13 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CO)(CO)[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CC=O)CC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCCOS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCOP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#C/C=C/C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)N=C=NC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(=O)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NC(O)C(Cl)(Cl)Cl)NC(O)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@H](N)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=C(CC)C(=O)NC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)CN(CC(C)O)CC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCCC(C)C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCOC(=O)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCCC)C(=O)N(CCCC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)NC(=O)CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCCCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCOS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCOS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCP(CCCC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=N)CC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](CSCCCO)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NCCCCNC(=N)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)N(O)N=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC/C=C/CCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(C(Cl)(Cl)Cl)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)O/N=C/C(C)(C)S(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule II for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)CS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC[N+](C)(C)CC=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)/C=C(C)/C=C/C[C@@H](C)CCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C)(C)CCC[C@H](C)C/C=C/C(C)=C/C(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCS(=O)(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(CC)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(CO)(CO)[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(CC)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCl)NCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule SCCCCCCCCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(O)CCCC(C)CCCC(C)CCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCOCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(C)CC(O)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(N)(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CC(=O)C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C(Br)CBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC=C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCC(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=O)(OC)C(O)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](N)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CC(O)CCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[Si](C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCOCCN(C)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)CCC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCC=CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)NNC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCN(CC)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)CC(S)CS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)NCCC[Si](OCC)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[Si](CC(C)C)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])C(Br)(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCOC(=O)CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[C@@H](C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule SCCSCCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNC(C)(C)[PH](=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[Si](CCCSSSSCCC[Si](OCC)(OCC)OCC)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=COC(=O)C(C)(CC)CCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCSCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(O)C[O][Na] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=COCCOCCOCCOC=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC=C(C=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(C=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(O)C(CC)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(C)(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C(C)/C=C/C=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)O/N=C(\\C)C(C)S(C)(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(C)(N)C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Ca+2] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)OC(C)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CC(=O)O)CC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCOC(=O)CC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCI for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCI for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)/C=C\\C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCCOCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(CO)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)CC(O)CC(=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[SiH](O[Si](C)(C)C)O[Si](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])OCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(C)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC(C)C[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)/C=C(\\C)OP(=O)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCS(=O)(=O)CCSP(=O)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)OCCOCCOC(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOC(=O)CC(CC(=O)OCCCCCC)(OC(=O)CCC)C(=O)OCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CC(C(=O)O)C(CC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)C(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)CN(CCCN(C)C)CCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCNCCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[N+](CCC)(CCC)CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(CSCC(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)CCOC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CC(=O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCCC)C(=S)[S][Ni][S]C(=S)N(CCCC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Ni+2] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC(=O)OC[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CCCCCCCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CN)CCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])[O][Cd][O][N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ATAD5, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCCCO)N=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(N=O)C(=N)N[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). these structural features indicate this compound may exhibit cellular stress response (SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cl)COP(=O)(OCC(C)Cl)OCC(C)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(Cl)C(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(COC(C)=O)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)CCCCCCCC(=O)OCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](COP(=O)(O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)CC[C@@H](N)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C[C@@H](N)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NNC(N)=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)NCCC[Si](OC)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCS(=O)(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCOCCOC(=O)C(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(N)=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(O)CCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC(C)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)SCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NCCC[C@H](N)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[CH2][Ge]([Cl])([CH2]C)[CH2]C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=O)(OC)OC(Br)C(Cl)(Cl)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC/C(C)=C/COC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(CO)C(O)C(=O)NCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[CH2][Sn]([Cl])([CH2]CCC)[CH2]CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCOC(=O)CCCCC(=O)OCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOC(=O)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C)(C)CC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCC(O)(P(=O)(O)O)P(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C)COC(C)COC(C)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCOCC#CCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCOCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)C(=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCN(CCO)CCN(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)SSC(C)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CC(O)C(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CC(Br)(Br)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde, 3 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(Br)(Br)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCCCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCNCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)CNCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)C(=O)OCCOCCOCCOCCOC(=O)C(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[Si](OC(C)=O)(OC(C)=O)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOCC(C)OCC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CS)OCCOC(=O)CS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)N(CC)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC(=O)N(CCO)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(CCC=C(C)C)OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(CO)(CO)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N[C@@H]([C@@H](O)[C@H](O)[C@H](O)CO)[C@@H](O)CC(=O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(=O)CCCCCC/C=C/C[C@@H](O)[C@H](O)[C@@](N)(CO)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)OCCC(C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=S)SSC(=S)N(CC)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-AhR, NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)/C=C/C(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCSCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C[N+](C)(C)C)OC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)C(Cl)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)C(C)(COC(N)=O)COC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)N[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. HIGH-RISK FEATURES: nitro group (potential mutagenicity). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)OOC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCO)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NCCNC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC/C(C)=C/CC/C(C)=C/CCC(=O)OC/C=C(\\C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)C(F)(F)C(F)(F)C(F)(F)CCI for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. MODERATE-RISK: 10 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CCOC(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[PH](=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(CCC=C(C)C)OC(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC(O)C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCC(C)OCC(C)OCC(C)OC(=O)C=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C(/C)C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(CO)CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)OCC(O)C(O)COS(C)(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCN(CC=C)CC=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NCO)NCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC/C=C/C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCSC(=O)N(CC(C)C)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCCCCCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCl)C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-ER, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC(=O)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCCCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#[C][AuH][C]#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(Br)(CC)C(=O)NC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)C(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C(\\C)C(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)C(=O)OCCOCCOCCOC(=O)C(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCSC(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)COC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. MODERATE-RISK: 18 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)C(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC=CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(=O)OCC(C)(C)C(OC(=O)C(C)C)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[Si](C)(C)O[Si](O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCOP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(Cl)(Cl)C(F)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(CC)C(C)CCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CCCCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#[C][Fe-2]([C]#N)([C]#N)([C]#N)([C]#N)[N]=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CCOC(=O)/C=C(C)/C=C/CC(C)CCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C)(C)CCCC(C)C/C=C/C(C)=C/C(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCC(CO)CCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)NCOCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOC(=O)CCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. MODERATE-RISK: 21 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=C(C)C(=O)OCCC(C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. MODERATE-RISK: 13 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOC(=O)CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCSC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][Sn]([Cl])([Cl])[Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[Si]=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)[C@H](C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(COC(C)(C)C)OCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)SCSC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)/C=C/C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)/C=C\\C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN=C=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=O)(OC)O/C(C)=C/C(=O)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCCOCOCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCN(C)CCCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCOCCOCCOCCCN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic linear or acyclic framework. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[As](C)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic linear or acyclic framework. MODERATE-RISK: 17 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 11 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic linear or acyclic framework. MODERATE-RISK: 19 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)[C@@H](O)CC(=O)O)C(C)C)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 14 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(=O)OCC(C)(C)C(O)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(N)(=O)SC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCSP(=O)(SCCCC)SCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CCC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)CSP(=O)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)=CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCN(CCCCCCCCCCCC)CCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCCCCCCCCCOC(=O)C(=C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)CC(O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOCC(CC)(CO)COCC=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(CCC(C)C)C(=O)[O][Sn]([CH3])([CH3])[O]C(=O)C(C)(CC)CCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CP(=S)(S)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity linear or acyclic framework. Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCOCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNC(=O)NC(=O)/C(C#N)=N/OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCNCC=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC/C=C/C=C/C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)NC(C)(C)CC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(C)(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NNC(=S)NN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC/C=C\\CCC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C)C(O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C/C(C)=C/C/C=C(\\C)CCC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCOS(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOC(=O)CCCCC(=O)OCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC/C=C/CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. MODERATE-RISK: reactive aldehyde, 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)N(C(=O)SCC(Cl)=CCl)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic linear or acyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCOC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCCCCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic linear or acyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)CI for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic linear or acyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule IC(I)I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOCC(CO)(COCC=C)COCC=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar linear or acyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)OC(F)(F)C(F)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity linear or acyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(Cl)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(O)cc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)[C@H](O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccccc1S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Nc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(C)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)N(c1ccccc1)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cccc(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCCCOP(OCCCCCCCC(C)C)Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(CC)Sc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCCC/C(=N\\OCCN)c1ccc(C(F)(F)F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(N)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(Cl)cc(Cl)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOc1c(Br)cc(Br)cc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(=O)O)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C(=O)O)ccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NC[C@@H](O)COc1ccc(CC(N)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc([N+](=O)[O-])cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc(C(F)(F)F)cc([N+](=O)[O-])c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCC(=O)c1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N)c(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc([As](=O)(O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ONc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(=O)C(=O)O)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1c(Cl)ccc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(C)(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(Cl)cc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1cc([N+](=O)[O-])cc(C(C)(C)C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCc1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc([N+](=O)[O-])c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCc1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)COc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)Nc1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)c1ccc(C(=O)OCC(CC)CCCC)c(C(=O)OCC(CC)CCCC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(O)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)OCC(COC(N)=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNC(C)Cc1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(NC(C)C)Oc1ccccc1C(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C=CC(=O)OCCC(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)OCC(O)COc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COC(=O)COc1cc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCc1ccc(O)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1c(Br)cc(Br)c(C)c1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1ccccc1OC(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)c1cc(C(=O)Cl)cc(C(=O)Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)cc(C)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccc(CBr)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule S=C=NCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1cccc(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(Cc1c(I)cc(I)c(O)c1I)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1cc(NC(C)=O)ccc1C(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(N)cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C=Nc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)c1ccccc1C(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=Cc1ccc(S(=O)(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc(C(F)(F)F)c(Cl)c([N+](=O)[O-])c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(C(F)(F)F)ccc1S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)SCC(CC(=O)c1ccc(C)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NC[C@H](O)c1ccc(O)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC/C=C\\C/C=C\\CCCCCCCC(=O)NC(C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(NN)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(C)C(=O)Oc1cccc([C@H](C)N(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(C)C(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C(=O)O)c1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOc1ccc(CC(=O)O)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-ER, NR-ER-LBD, NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NNc1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOc1ccccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cccc(C)c1N(C(=O)CCl)[C@@H](C)COC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc(C(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CNC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1cccc(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C[C@@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1NC(=O)CN(CC(=O)O)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc(O)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCc1ccc(OC)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCNC(=O)COc1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(CC(C)N)c(OC)cc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1cccc(C(C)C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(OC)c(OC)cc1C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(N)=O)cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)Nc1c([N+](=O)[O-])cc(C(C)(C)C)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(C(Cl)(Cl)Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CBr)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C=O)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCNC(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCc1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccc(NC(C)=O)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1cc(Cl)c(NC(C)=O)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc(O)c(C(N)=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)Nc1ccc(O)c(C(C)=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(=O)Nc1ccc(C)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(Cl)c(OC)cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCOC(=O)c1cc(O)c(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCOc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)c(N)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N(CCO)CCO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)Nc1cccc(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C(=O)NC(=O)NC(C)=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1cc(OCC)c(C(C)=O)cc1OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)c1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=S)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNP(=O)(OC)Oc1ccc(C(C)(C)C)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)NNc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(NC(=O)CC(C)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(NC(N)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccccc1C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(OC)Oc1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(N)ccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc([N+](=O)[O-])cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)c1cc(Cl)cc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc([N+](=O)[O-])ccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(N)cccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(CNC(=O)c1ccccc1OCC(=O)O)[CH2][Hg][OH] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1cc([As](=O)(O)O)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCNC(=O)c1ccc(NS(C)(=O)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER) and cellular stress response (SR-ARE, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)c1ccccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C(=O)O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Sc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(C=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1cccc(C(C)C)c1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(C(=O)O)c(C(=O)O)cc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(S(=O)(=O)O)c(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[Si](OCC)(OCC)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccc(OC(=O)CCCCCNC(=N)N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)COc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)COc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)Nc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Oc1cc(Cl)ccc1Cl)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Oc1ccc(Cl)cc1Cl)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)COc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)COc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cccc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)SCc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)NC(=S)Nc1ccccc1NC(=S)NC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1cc(CCC(=O)NN)cc(C(C)(C)C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOC(=O)c1ccccc1C(=O)OCCOCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1cc(S(N)(=O)=O)ccc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCC(O)COc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)CNC(=O)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOc1cc(Cl)ccc1C(=O)NCCN(CC)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1c(Cl)cc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc(Cl)c(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cc(Cl)cc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(Cl)ccc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)c(O)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@](N)(Cc1ccc(O)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CCO)c1cccc(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CC=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C/C=C/c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C)ccc1C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc(C(=O)N=C(N)N)cc1S(C)(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC(O)c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc(O)c(C(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(=O)OCCOc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)c1cc(O)c(C(C)(C)CC)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NCC(O)c1ccc(O)c(CO)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C[C@H](NC(=O)OCc1ccccc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccccc1C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)c1ccccc1C(=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(O)cc1C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1ccccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc(C=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)c1cccc(C(C)CC)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC[N+](C)(C)CCOc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NCC(O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCOC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COC(=O)c1ccccc1C(=O)OCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCOc1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCOc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=Cc1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)Nc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Cl)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(OC(=O)CC(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)OC(=O)c1ccccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(/C=C/C(N)=O)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)C(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(C(=O)O)cc(S(=O)(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: reactive aldehyde. these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: reactive aldehyde. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCc1ccccc1OCC(O)CNC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(NC(C)=O)cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)Cc1ccc(OCC(=O)N(CC)CC)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Oc1cc(C)c(N(C)C)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(N)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Br)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(O)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNS(=O)(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)c1cccc(C(=C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=N)NC(=O)Nc1c(C)cccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=S)c1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc(S(=O)(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCS(=O)(=O)Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Oc1cccc(C(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)Nc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCNC(C(=O)OCCC(C)C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNC(=O)/C=C/c1cccc(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(SC#N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(OCC(O)CNC(C)(C)C)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CC=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)OC(C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)c1c(Cl)c(Cl)c(C(=O)Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(N=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(S(=O)(=O)N[C@@H](CCCCN)C(=O)CCl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NCC(O)c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(S(=O)(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(O)c(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N)cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCN(CCO)c1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1NC(=O)CC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(C)C)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCCOc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(N)(=S)Oc1ccccc1C(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCOC(=O)c1ccccc1C(=O)OCCCCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC(CC)c1ccc(S(=O)(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1c(Cl)ccc(Cl)c1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1ccc(Br)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1OCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(CC)OC(=O)CCCOc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Fc1c(F)c(F)c(Br)c(F)c1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C(\\C)C(=O)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1ccc([N+](=O)[O-])cc1CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)COc1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC(O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NO)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccccc1C(=O)OCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)Oc1ccc(CCNC(=O)[C@H](CCSC)NC(C)=O)cc1OC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCc1ccccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(CCO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccccc1CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc(Br)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCOC(=O)COc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NC(=N)NCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc([N+](=O)[O-])ccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccc(N(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(=O)OCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1cccc(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(OC)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(N)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc(C(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)/C(C#N)=C/c1cc(O)c(O)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCOC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(CCC(C)=O)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@H](C(=O)O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCl)NCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(/C=C/C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(S(N)(=O)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)c1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)c(C)c(C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNC(=O)NS(=O)(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccccc1C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-ER) and cellular stress response (SR-ATAD5, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)Nc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CC(C)(C)NC(=O)c1cc(Cl)cc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(Cl)c(N)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(Cl)cc([N+](=O)[O-])cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)Nc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NNC(=O)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc(C#N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C)cc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccccc1CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(CCl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)c1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cccc(CCl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)c1cccc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)c1ccccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(S(=O)(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCCC)C(C(N)=O)c1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CC(=O)Nc1c(C)cccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(COc1ccc(C(C)(C)C)cc1)OS(=O)OCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN[C@H](C)Cc1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@H](C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@@H](C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](N)C(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](N)C(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN[C@@H](C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[O][Hg][c]1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1ccccc1C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Oc1ccc(N(C)C)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC[C@H](O)c1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN/C=N/c1ccc(C)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Fc1cccc(Cl)c1CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(=O)/C(Br)=C\\C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(Cl)ccc1/N=C/N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1cc(OCC)c(C(=O)CCC(=O)O)cc1OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(N)c1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(N=C=O)c1cccc(C(C)(C)N=C=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(=O)OCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOc1ccccc1OCC(O)CNC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCNCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1cc(O)ccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(OC)Oc1ccc(SC)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)Nc1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)c1ccccc1C(=O)OCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc(N(CCO)CCO)ccc1NCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N(CC(C)C(=O)O)c1c(I)cc(I)c(N)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C=O)Cc1ccc(C(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCl)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(OC)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)c(Cl)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1ccc([N+](=O)[O-])cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C(C)(C)C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(=O)CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CC(=O)Oc1ccc(NC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1cccc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cccc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)c1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C=O)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)O/N=C(\\C#N)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOC(=O)c1ccccc1C(=O)OCCOC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(CCN)c(OC)cc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C[C@@H](C)N)c(OC)cc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(CCN)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCSc1cc(OC)c(CCN)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C[C@H](C)N)c(OC)cc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(CC(C)C)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC(O)c1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)c(N)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1cccc(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(=O)Nc1ccc(S(=O)(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)/C=C/c1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)OC(C)(C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1cc(C(C)C)cc(C(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCNC(C)C(=O)Nc1ccccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(CC)(CNC(=O)CCCO)c1cccc(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1cc(C=O)cc(C(C)(C)C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)NC(C)(C)Cc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)OCc1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC(O)c1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(Cl)c(OCC(O)CNC(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C(=O)OCCN(CC)CC)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)c1ccccc1C(=O)OCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Oc1ccccc1OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(=O)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(NC(C)=O)cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)c1ccc(C(=O)OCC(CC)CCCC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ICCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cccc(I)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(NC(=O)CC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cc(Cl)c(OCC#CI)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=S)NS(=O)(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)/C=C/c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CON(C)C(=O)Nc1ccc(Br)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)Nc1c(I)cc(I)c(CC(CC)C(=O)O)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(Cl)cc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(Cl)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(Cl)c([N+](=O)[O-])cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(NC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(Cl)cc(S(=O)(=O)O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1cccc(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(OC)c(NC(=O)CC(C)=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1cc(O)c(O)c(S(=O)(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NNC(=O)c1cccc(C(=O)NN)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])C=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD) and cellular stress response (SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=O)(OC)O/C(=C\\Cl)c1cc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CSCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1cc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(C)(C)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC[C@H](O)c1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)N(C(=O)CCl)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCc1cc(OC)c(O)c(C(=O)NCCO)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccccc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(Br)cc([N+](=O)[O-])cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(=O)Nc1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1cccc(Cl)c1)OCC#CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-HSE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccccc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(N(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NN=Cc1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCC(=O)NCc1ccc(O)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc([N+](=O)[O-])cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(N)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCN(CCO)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1cc(C=O)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C=O)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1cc(O)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(Cl)cc([N+](=O)[O-])c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](N)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)OC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=Cc1ccc(OC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1cccc(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cccc(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COC(=O)C=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)Nc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cccc(C)c1N(C(=O)CCl)C(C)COC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Fc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(CCC=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC/C(=C/c1ccccc1)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(CBr)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Cc1ccc([C@H](C)C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COC(=O)COc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)COc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(Br)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCN(CCCOC)C(=O)C(CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC(C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(S(=O)(=O)O)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCOC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(Br)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(Cl)c(Cl)cc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(S(=O)(=O)O)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(N=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-AhR, NR-ER) and cellular stress response (SR-ATAD5, SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)OC(=O)c1cccc(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc([N+](=O)[O-])cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc([N+](=O)[O-])c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc([N+](=O)[O-])c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)cc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(OC)Oc1ccc(S(=O)(=O)N(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)NC(=S)Nc1ccccc1NC(=S)NC(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=Cc1cccc(CCl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=Cc1ccc(C(C)(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)c1ccc([C@@H](O)[C@@H](COC(=O)CN)NC(=O)C(Cl)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)c(Cl)c(C)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])/C=C/c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). these structural features indicate this compound may exhibit cellular stress response (SR-ATAD5, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(C=O)=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)c1c(Br)c(Br)c(Br)c(Br)c1C(=O)OCC(CC)CCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(OC)Oc1cc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)c1ccc(O)c(C(C)(C)CC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)CC(C)(C)c1ccc(OCCO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(CCC=C(C)C)OC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1ccc(O)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(S(N)(=O)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CON(C)C(=O)Nc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(C(=O)O)cc(C(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=O)(OC)Oc1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccc(C(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(C(=O)O)c(C(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccc(C(=O)O)c1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)c1cc(C(=O)OC(C)C)cc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(S(=O)(=O)O)cc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Oc1cc(C)cc(C(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+](C)(C)Cc1ccccc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)c(C(=O)O)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOc1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(S)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)C=Cc1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCSP(=S)(OCC)Oc1ccc(SC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(Cl)ccc1OCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CS)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)NC(=O)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCC)c1c([N+](=O)[O-])cc(S(N)(=O)=O)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C)cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NC(=O)c1ccc(C=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(CC#N)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CC(C)(CC)OC(=O)c1ccccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[CH2][Hg][S]c1ccccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(Br)c(O)c(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1c(C)cc(O)c(C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)c1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C#N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NCc1cccc(CN)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCNC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(C(Cl)=C(Cl)Cl)c(S(N)(=O)=O)cc1S(N)(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(OCC)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(S(=O)(=O)O)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1ccc(C(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-ATAD5, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(Cl)cc(C(=O)O)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C#N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1cc(O)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)c(C)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-HSE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1cc(Cl)ccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)CN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1NC(=O)C(C)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCC(=O)NCc1ccc(O)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cccc(S(=O)(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(Cl)ccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[PH](O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@H](C(=O)O)[C@@H](O)c1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CNC(=O)c1ccccc1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNC(=O)NCc1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)C(=O)OCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CN(C)C)C(C)(O)Cc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C=Cc1ccc(C=CC(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CO)Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CBr)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)c1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1cccc(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc([N+](=O)[O-])c(O)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc([N+](=O)[O-])c1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1cccc(C(=O)O)c1OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)Nc1ccc([As](=O)(O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)NNc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(I)cc(I)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CC(=O)C(F)(F)F)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1cc(O)ccc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(C(N)=O)cc([N+](=O)[O-])cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCc1ccc(S(=O)(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Nc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc(I)c(O)c(I)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCCc1ccc(OCCOCCO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(C(Cl)(Cl)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cccc(C)c1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCC(O)COc1ccc(NC(=O)CC[S+](C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNNCc1ccc(C(=O)NC(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(Cl)c(C)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1c(C)c([N+](=O)[O-])c(C(C)(C)C)c([N+](=O)[O-])c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1OCC(C)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(OC)c(C(O)C(C)N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(Cl)ccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](Cc1ccccc1)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNCC(O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)N(Cc1ccccc1)C(=O)C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(CCC=C(C)C)OC(=O)c1ccccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1ccc(C=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c([N+](=O)[O-])c(C)c([N+](=O)[O-])c(C(C)(C)C)c1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCSP(=S)(OCC)Oc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)Oc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cccc(CC)c1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C)c(S(=O)(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]([C@H](O)c1ccccc1)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)CC(C)(C)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)NC(Cc1ccccc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)S(=O)(=O)c1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(Cl)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccccc1CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(NC(C)C)Oc1ccc(SC)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)COC(=O)c1ccccc1C(=O)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C(\\C)C(=O)OCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CC(C)N(C)C(=O)Nc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOC(=O)c1ccc(C(=O)OCC=C)c(C(=O)OCC=C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC(O)COc1ccc(CC(N)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCNC(C)(C)COC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)ccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(Cl)cc(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCCl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(OC)Oc1ccc([N+](=O)[O-])c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)c(C(C)(C)C)cc1C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(Cl)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(Cl)ccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)NS(=O)(=O)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(CC)Nc1ccc(C)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)NCc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CON(C)C(=O)Nc1ccc(Br)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1c(Cl)ccc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)/C=C/c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCOC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ATAD5, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCOC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(F)cc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOC(=O)c1ccccc1C(=O)OCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Oc1cccc(N=CN(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(Cl)cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(N)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Cl)cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AhR) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Cl)c(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNS(=O)(=O)c1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CCN)c1cccc(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CNc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(C)Cc1ccccc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(OC)Oc1ccc(S(N)(=O)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(C)NC(=O)[C@@H](NC(=O)OC(C)C)C(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1c(Br)c(Br)c(Br)c(Br)c1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(Cc1ccccc1)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+](C)(C)c1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCNC(=O)c1ccc(NC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(OCC)OC(=CCl)c1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C=Nc1c(I)cc(I)c(CCC(=O)O)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1c(I)c(C(=O)O)c(I)c(N(C)C(C)=O)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NCC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(N(CCO)C(=O)CO)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](Cc1ccc(O)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOC(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(N)cc(C(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)(Cl)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NNC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](N)[C@@H](O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C(=O)OCCOCCN(CC)CC)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1ccc(NC(=O)CCC(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(Cl)c(O)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc[c]([Hg][Cl])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(OC)c(C(O)CNC(=O)CN)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1cccc(C#N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)OC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(NC(=O)N(C)C)cc1NC(=O)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1c(F)cccc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule SCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCc1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(NCCO)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(COC=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(C)CC(C)CC(C)COC(=O)c1ccccc1C(=O)OCC(C)CC(C)CC(C)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C(=O)NCCCCCC(=O)O)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)NS(=O)(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOc1ccccc1C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)/C=C/c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cccc(CC)c1NC(=O)CN(CC(=O)O)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OCCO)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)S(=O)(=O)N(SC(F)(Cl)Cl)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cc(Cl)c(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(C(=O)OCC(O)CO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C[C@H](C)N)c(OC)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(C(=O)O)ccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1OCC(O)COC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOC(=O)COc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(=C\\c1ccccc1)[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)c(C(C)C)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)COc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)c(NC(=O)CN(CC(=O)O)CC(=O)O)c(C)c1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CCOC(=O)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(OC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCc1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[Si](OC)(OC)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCc1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cc(O)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccc(C(=O)OC)c(C(=O)OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCCCCCCC#CI)Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNc1ccc(C(=O)OCCN(CC)CC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)c1cc(O)c(O)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(CC(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCCOC(=O)C=Cc1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1cccc(C(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)c1cccc(C(=O)Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(C(=O)O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc(O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(OO)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(C(=O)OCCN(CC)CC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(C(=O)O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNC(=O)C(C)OC(=O)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(N)Cc1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccc(C=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cccc[c]1[Hg][Cl] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CC(=O)Nc1c(C)cc(C)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)OOC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OP(=S)(OC(C)C)SCCNS(=O)(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1ccccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(NC(=O)c1cc(Cl)c(C)c(Cl)c1)C(=O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(Cl)cc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C=O)=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[CH2][Sn]([CH2]CCC)([CH2]CCC)[O]C(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cccc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(O)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(C(=O)CCCCl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(C)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(N=O)c1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(COc1ccccc1)NN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(CC)Oc1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)c1ccc(C(C)(C)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cc(Cl)cc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cccc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cc(Cl)ccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCC)c1c([N+](=O)[O-])cc(C(C)C)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCN(C(=O)CCl)c1c(CC)cccc1CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccc(F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Cc1ccc(C(C)C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCSP(=O)(OCC)Oc1ccc(Br)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(CCl)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(C=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(=O)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)OC/C=C/c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)OCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(=O)OCC=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc([As](=O)(O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc([N+](=O)[O-])c1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(C(=O)O)cccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCC)c1c([N+](=O)[O-])cc(S(C)(=O)=O)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Oc1cccc(Cl)c1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccc(F)c(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(O)COc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(O)Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)c1c(O)cc(O)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1N=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOc1cc(C)c(O)c(C)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cccc(CC)c1N(COC)C(=O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCCCCC(=O)Nc1ccccc1)NO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ATAD5, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](N)[C@H](O)c1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(C(Cl)(Cl)Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNc1ccc(C(=O)OCCN(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Oc1c(C(C)(C)C)cc(C)cc1C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(CN(C)C)OC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCC(O)c1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cc(Cl)c(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1NC(=N)NC(=N)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(OCC)Oc1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(NC=O)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CCC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CC(=O)Nc1c(C)cccc1C(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N(CC(=O)N(C)C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCCl)c1ccc(F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccc(Cl)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: reactive aldehyde, 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1cc(Cl)ccc1NS(=O)(=O)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccccc1C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(NC(=O)CC(C)=O)c(OC)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(Br)c(Br)c(Br)c(Br)c1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(Cc1ccc(Cl)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc([N+](=O)[O-])ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc([N+](=O)[O-])cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(O)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)Nc1cc(C#N)cc(NC(=O)COC(C)=O)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)c1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C=Nc1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=Cc1ccc(C=C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1cc(C(=O)OC)cc(S(=O)(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1cc(O)c(C(C)(C)C)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCOC(=O)c1ccccc1C(=O)OCCCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)CCc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)cc(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Cc1ccc(CC(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(C)(CCC=C(C)C)OC(=O)C=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C/C(=O)Oc1c(CCCCCC(C)C)cc([N+](=O)[O-])cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCSc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccccc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc(C=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)SCSc1cc(Cl)ccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(N)cccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCc1cc(O)c(O)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=Cc1ccccc1C=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1OCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCc1cc(O)cc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)Cc1cc(CN(C)C)c(O)c(CN(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCOC(=O)c1ccccc1C(=O)OCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)c1ccccc1C(=O)OCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccc(I)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(CCO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Oc1ccccc1C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc(NC(=O)N(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(C)C)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)C=Cc1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc(C(F)(F)F)ccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(Cl)c(OC)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC=C(C=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Sc1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCS(=O)(=O)c1ccc(OC)c(C(=O)OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCc1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CCO)CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Fc1cc(Br)ccc1CBr for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(/C(C)=C/C(=O)O)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CC(C#N)(c1ccccc1)C(C)C)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc([N+](=O)[O-])c(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(NCCO)c(OCCO)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NC(=O)Cc1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)OCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(Cl)cccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc([N+](=O)[O-])ccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C(=O)NC(N)=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1ccc(N(CC(N)=O)CC(F)(F)F)cc1C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(/C=C/c1ccccc1)NCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(O)C(Sc1ccc(Cl)cc1)P(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)c1cc(O)c(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(O)c(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CCc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(Cl)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COC(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(S(=O)(=O)O)c(N)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N)c(S(=O)(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(C)(C)C)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(N)c(S(=O)(=O)O)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOc1ccc(CC(=O)NO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)c1cccc(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1ccc(Br)c(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)CC(C)(C)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1c(Cl)c(Cl)c(C(=O)OC)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCOCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(N)cccc1C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1c(C)cc(C(C)(C)C)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC#N)c1cccc(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CNC(=O)c1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=Cc1cccc(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC(C)(C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CON(C)C(=O)Nc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1cc(Br)c(O)c(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AhR) and cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1cc(I)c(O)c(I)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCOc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(COC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)C(=O)c1ccc(OCCO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(N=C=O)cccc1N=C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=NN(O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CO)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)NS(=O)(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCNC(=O)COc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCCc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)Cc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCCO)c(I)c(C(=O)NCC(O)CO)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cc(Cl)cc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cccc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCl)c1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-ATAD5, SR-HSE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOc1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cc(Cl)c(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C=O)Cc1ccc(C(C)(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCC(CC(=O)O)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(S(N)(=O)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Oc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(OC)C(C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1ccccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1cccc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cccc(S(=O)(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)CCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cc(OC)c(C[C@H](C)N)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cc(OC)c(C[C@@H](C)N)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(OC)c(CC(C)N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C[C@@H](C)N)c(OC)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=Cc1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C/c1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NNCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AhR, NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NNc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC[C@H](O)c1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(S(=O)(=O)O)ccc1S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(N)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(O)c(C(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc(OC)c1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(=O)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(SP(=S)(OC)OC)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cc1ccccc1)NCCCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC[C@@H](NC(C)=O)C(=O)NCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(Oc1ccc(Cl)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=CC(=O)N(CC)c1ccccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(O)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC(c1ccccc1)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C\\c1ccc(OCC)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(N=NS(=O)(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(CO)C(=O)NNCc1ccc(O)c(O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(Br)cc(Br)cc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCOC(=O)c1ccccc1C(=O)OCCCCCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)Oc1ccc(S(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NS(=O)(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(Br)ccc1NC(=O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(S(N)(=O)=O)cc(C(=O)O)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(C=O)=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cc[c]([Hg][Cl])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1cc(Cl)cc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(NC(=S)N(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC[N+](C)(C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(Cl)cc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Oc1cc(Cl)c(Cl)cc1Cl)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)COc1cc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(NC(=O)OC(C)C)cc1OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)SCSc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1cccc(S(=O)(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc([N+](=O)[O-])c(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNc1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOC(=O)c1ccccc1C(=O)OCC=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cccc(O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1cc(Cl)ccc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc(CC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOCCOC(=O)C(CC)(CC)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(CC)Nc1c([N+](=O)[O-])cc(C)c(C)c1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase, NR-ER) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cc(Cl)c(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1OP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOc1cc(C(=O)OCCN(CC)CC)ccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)OCCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccc(O)c(O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(NC(C)C)Oc1ccc(C)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(Br)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](Cc1cc(I)c(O)c(I)c1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc(CO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC(O)c1ccc(N)c(C#N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NP(N)(=O)NC(=O)c1ccc(F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc([N+](=O)[O-])cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccc(C(=O)OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)NC(=O)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc(C=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C=Cc1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCOC(=O)C=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][Hg][c]1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(NC(N)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N=C=O)cc1N=C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1S(N)(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccccc1OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(Cl)ccc1N=CN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)Oc1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(OC)c(C[C@H](C)N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCc1ccc(O)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1C(=O)OCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)CC[C@H](Nc1ccc([N+](=O)[O-])cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(Cl)c(N)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCc1ccc(COC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(C(=O)O)c(O)c(S(=O)(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccccc1C(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(Cc1ccc(F)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(F)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)c1ccccc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CNc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1ccccc1C#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CCc1ccc(OC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCOC(=O)c1ccc(C(=O)OCCCCCCCC)c(C(=O)OCCCCCCCC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C=O)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NC(=O)c1ccccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CONC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Fc1ccc(Br)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(/C=N/NC(N)=S)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(C(=O)NCC(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[Si](CCCNc1ccccc1)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CCN(C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(Cc1ccccc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCOc1cccc(OCCO)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1cc(CO)cc(C(C)(C)C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(Cl)cc(Cl)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CSc1ccc([N+](=O)[O-])cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc([N+](=O)[O-])cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNCC(O)c1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(O)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(=O)Nc1ccccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](N)[C@H](O)c1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(C)C(O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(F)cc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(Cl)ccc1OCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(Cl)ccc1OC(C)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule S=C=NCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOC(=O)c1ccccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)N=Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule S=C=Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(S)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCOC(=O)c1cc(O)c(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)(Cl)c1ccc(C(Cl)(Cl)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNS(=O)(=O)c1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1OCC(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1cccc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOc1ccccc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC(C#N)=NNc1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1cccc(C(=O)OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(=O)c1ccccc1)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCCOC(=O)c1ccc(C(=O)OCCCCCCC(C)C)c(C(=O)OCCCCCCC(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1/C=C/C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccccc1S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)c(C)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)c1ccc(N(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)c1ccc(C(=O)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(NC(=O)CC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)C(=O)[O][Hg][c]1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N)cc1S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)COc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(Cl)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD) and cellular stress response (SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)ccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(O)c1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(S(=O)(=O)O)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCOC(=O)c1ccc(N(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cc(O)cc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCOC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)c(C)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COC(=O)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCCCOC(=O)c1ccc(C(=O)OCCCCCCCC(C)C)c(C(=O)OCCCCCCCC(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=O)(OC)OC(=CCl)c1cc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCN(CCCCC)C(=O)C(CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCSCc1ccccc1OC(=O)NC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C(=O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CBr)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)cc(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(S(=O)(=O)O)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C)c(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(N)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=Cc1ccc(O)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(S(=O)(=O)N(Cl)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(OC)Oc1c(Cl)cc(C)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)Nc1ccc(NC(C)CC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClP(Cl)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(O)cccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(CO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(N)Cc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)COc1ccc(Cl)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(O)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)cc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(N)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)COC(=O)c1ccccc1C(=O)OCCCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC(=O)Oc1c(Br)cc(C#N)cc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCOc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER-LBD) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c([N+](=O)[O-])cccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc([N+](=O)[O-])cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)COc1cc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOC(=O)COc1cc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)c1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(F)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(CC)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)/C=C/c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(C(=O)O)cc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCN(C(=O)CCl)c1c(C)cccc1CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OB(O)[O][Hg][c]1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-ER-LBD) and cellular stress response (SR-ATAD5, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@@H](C)[C@H](O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(O)c(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1c(Cl)c(Cl)cc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc(Cl)c(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD) and cellular stress response (SR-ARE, SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1c(C(C)(C)C)cc([N+](=O)[O-])c(C)c1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)c1ccccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(NC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCc1ccc(Br)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)COc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(NC(C)C)C(O)c1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1cccc(C(C)(C)C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(Cl)ccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde, 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cl)c1ccc(F)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(Cl)c1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CCOC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)Oc1cc(Cl)c(Br)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NCC(O)c1cc(Cl)c(N)c(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCc1ccc(C)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)Nc1cccc(OC(=O)NC(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NCc1ccc(S(N)(=O)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[Si](C)(OC)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(S(=O)(=O)NCl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CSc1ccc(N)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(N)Cc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(OC)cc(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOC(=O)c1ccc(N)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)c1ccc(O)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC(C#N)=Cc1cc(O)c(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC(C#N)=Cc1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N(SC(F)(Cl)Cl)S(=O)(=O)N(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(S(=O)(=O)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc([N+](=O)[O-])cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccccc1C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCC(=O)N(c1c(C)cccc1C)C(C)C(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation), aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)Nc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(S(=O)(=O)N=C=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NC(C)Cc1ccc(I)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CCN(C)CCCOc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1c(Cl)c(Cl)c(Cl)c(C#N)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ATAD5, SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C)c(O)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C=Nc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)Nc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CCO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1ccc(Cl)c(S(N)(=O)=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)OCCOc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C=O)ccc1OC(=O)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCl)NCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCC(O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCl)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(OC)Oc1ccc([N+](=O)[O-])cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(C(=O)CCl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)c1ccccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1OC(=O)C=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1OC(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)c1c([N+](=O)[O-])cc(C(F)(F)F)c(N)c1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(C)c([N+](=O)[O-])c(C(C)(C)C)c([N+](=O)[O-])c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CCN(C)[C@H](C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CCC#N)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCOC(=O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1nc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CSC(=O)c1c(C(F)F)nc(C(F)(F)F)c(C(=O)SC)c1CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccncc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccc(Cl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(Cc1ccc(Cl)nc1)/C(=C/[N+](=O)[O-])NC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc(CO)c(CN)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc(CO)c(CO)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCc1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOC(=O)c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1ccc(C(=O)O)nc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCNC(=O)c1ccc(Cl)cn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOC(=O)c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccc(C(=O)O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1nc(Cl)c(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCc1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCc1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NCC(O)c1ccc(O)c(CO)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(Cl)c(F)nc(OCC(=O)O)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(O)nc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCc1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(N/C(=N\\C#N)Nc1ccncc1)C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1nc(Cl)c(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOC(=O)COc1nc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccnc(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=NC#N)N(C)Cc1ccc(Cl)nc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(C)OC(=O)COc1nc(F)c(Cl)c(N)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cccc(C(Cl)(Cl)Cl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(=N/NC(=O)c1ccncc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NNC(=O)c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC(=O)c1cc(F)c(Cl)nc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOC(=O)c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc(COP(=O)(O)O)c(C=O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1nc(C(Cl)(Cl)Cl)c(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 7 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NNCS(=O)(=O)O)c1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NNC(=O)c1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cc(C(N)=S)ccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCc1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(C(Cl)(Cl)Cl)cn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=S)N/N=C/c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)OCc1cccc(COC(=O)NC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1nc(Cl)ccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCCc1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc(CO)c(C=O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc(C)c(Cl)c(O)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cnc(C(=O)O)c(C(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N)nc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NNC(=O)c1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NCCO[N+](=O)[O-])c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCc1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cccc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(Cl)c(Cl)nc(C(=O)O)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCc1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1nc(Cl)c(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ATAD5, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)COc1nc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)c1ccc(C(=O)OCCC)nc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=CC=NNC(=O)c1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1cc(C(N)=S)ccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccnc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCc1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(OCC)Oc1nc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase, NR-ER-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cc(C(Cl)(Cl)Cl)cnc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(OC)Oc1nc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cc(Cl)c(Cl)nc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)(c1ccc(Cl)cc1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCOC(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)CC(C)(C)c1ccc(O)c(Cc2ccc(Cl)cc2Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Cl)cc1Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(c1ccccc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(c1cc(Br)c(OCC(Br)CBr)c(Br)c1)c1cc(Br)c(OCC(Br)CBr)c(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 8 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@H](O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(C)(C)c2ccc(C)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)C(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc(C(c2ccc(CC)cc2)C(Cl)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Cl)cc1Cc1cc(Cl)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(C)(c1ccc(O)cc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Cc2ccc(O)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(Cc2cc(C)cc(C(C)(C)C)c2O)c(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(c1ccc(Cl)cc1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(c1cc(Cl)c(O)c(Cl)c1)c1cc(Cl)c(O)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(C(c2ccc(O)cc2)(C(F)(F)F)C(F)(F)F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(C(=O)OCCN(C)C)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOC(=O)C(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CS(=O)C(c1ccccc1)c1ccccc1)NO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCCCCOc1ccccc1Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOc1ccc(Cc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Cc2ccccc2O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](OC(C)=O)C(C[C@@H](C)NC)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccccc1Cc1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(c1ccc(O)cc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CCC(=O)O)(c1ccc(O)cc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(C(c2ccc(O)cc2)C(Cl)(Cl)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Cc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(c1cc(Br)c(OCCO)c(Br)c1)c1cc(Br)c(OCCO)c(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(C(c2ccccc2Cl)C(Cl)(Cl)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1cc(Cc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOC(=O)C(O)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(c1cc(Br)c(O)c(Br)c1)c1cc(Br)c(O)c(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Cc2ccc(N)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C(C)(C)c2ccc(O)c(C)c2)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(c1ccc(O)cc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(Cc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)C(O)(c1ccc(Cl)cc1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(c2ccc(OC)cc2)C(Cl)(Cl)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC(c1ccc(Cl)cc1)(c1ccc(Cl)cc1)C(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)Oc1ccc(Cc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)C(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-HSE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCC(O)COc1ccc(C(C)(C)c2ccc(OCC(O)COC(=O)C(=C)C)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(Cc2ccc(N)c(C)c2)ccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(Cc2ccc(N(C)C)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1C(OCCN(C)C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)CS(=O)C(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cc(Cc2cc(CC)cc(C(C)(C)C)c2O)c(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CC(C(N)=O)(c1ccccc1)c1ccccc1)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(C)c2ccc(C)c(C)c2)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(c1ccc(O)cc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(C(c2ccc(Cl)cc2)C(Cl)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CCOC(C(=O)OCCN(C)C)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOC(=O)C(C)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCSC(=O)C(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C=Nc1ccc(Cc2ccc(N=C=O)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cc(Cc2cc(CC)c(N)c(CC)c2)cc(CC)c1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CC(C#N)(c1ccccc1)c1ccccc1)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCOc1ccccc1Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOc1c(Br)cc(C(C)(C)c2cc(Br)c(OCC=C)c(Br)c2)cc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)CCOC(=O)C(O)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C(C)(C)c2cc(C)c(O)c(C)c2)cc(C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Cc2ccc(N)c(Cl)c2)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(c1ccc(Cl)cc1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(c1cc(C(C)(C)C)c(O)cc1C)c1cc(C(C)(C)C)c(O)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(O)(c1ccc(Cl)cc1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1cc(C)c(OC(C)=O)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1ccc2cccc(S(=O)(=O)O)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC(C)C(=O)OCC[N+](C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar linear or acyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc2cc(S(=O)(=O)O)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc2ccccc2c1S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2ccccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCOc1ccc(C(=N)N(CCCC)CCCC)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(O)c2c(O)cccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1ccc2ccccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2ccccc2c1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc2cc(C(=O)O)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(O)c2ccccc2c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2ccccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1ccc2cc(O)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)c2ccccc2c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)C(C)Oc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2ccccc2c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=S)Nc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2ccccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCNc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cccc2c(N)cccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)Cc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc2c(C(C)C)cc(C(C)C)c(S(=O)(=O)O)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc2cc(O)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Oc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2cc(C)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC(O)c1ccc2ccccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(N)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc2ccccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)COc1ccc2ccccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(=O)CCC(=O)O)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(C(=S)N(C)CC(=O)O)cccc2c1C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2cc(C=O)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2cc([C@H](C)C(=O)O)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NC[C@@H](O)COc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc2cc(S(=O)(=O)O)cc(O)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccc2cc(C(=O)OC)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)Cc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc2c(O)cc(S(=O)(=O)O)cc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC(O)COc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2cccc(CCNC(C)=O)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)Cc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2cc(CCC(C)=O)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc2ccccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc2cc(C(C)C)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc2ccccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2cc([C@H](C)CO)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc2ccccc2cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2c(C)cccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[N+](C)(C)CC(O)COc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1ccc2cc(O)c(S(=O)(=O)O)cc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cccc2cccc([N+](=O)[O-])c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc([N+](=O)[O-])c2ccc(S(=O)(=O)O)cc2c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc([N+](=O)[O-])c2ccccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cccc2c([N+](=O)[O-])cccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc2ccccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[C@H]1CC[C@H](C)C[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=COCC1CCC(CO)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C=NCC1CCCC(CN=C=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCCC1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC1(O)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNC(=O)C1CC(C)CCC1C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(C)CC1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)C1CCC(O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CC(N)CC(C)(CN)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC1CCC(C(C)(C)C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCC1(CC(=O)O)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CC(O)CC(C)(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OC1CC(C)CC(C)(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)NC1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC1CCCCC1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC1(N)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCC1CCC(C(=O)O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C=NC1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCC1CCCC(CN)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC1CCC(O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=NN(CCCl)C(=O)NC1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCC(Br)C1CCC(Br)C(Br)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule SC1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)[C@@H]1CC[C@@H](C)C[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CCC(NC(=O)[C@@H](N)CCC(=O)O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCC(C(C)CS)CC1S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)C1CCCCC1OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C1CCC(O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(C)(C)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(N)CCC(C(C)(C)N)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=COCC1CCC(COC=C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCC(C(C)C)C(O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCCOC(=O)C1CCCCC1C(=O)OCCCCCCC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CC1(O)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC1CCCCC1C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C1CCC(C(=O)OC)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C1CCC(O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCC(CO)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C1CCC(C)(O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOC(=O)CCC1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC1CCC(CO)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@H]1CC[C@H](C(=O)OC)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(O)CCC(C(C)(C)O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)C1CCC(OC)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCCC1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1C[C@@H](O)CC(C)(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@H](Cl)[C@@H](Cl)[C@@H]1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H](Cl)[C@H]1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C1CCCCC1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCSC(=O)N(CC)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1cc[n+](C)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCn1cc[n+](C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[n+]1ccn(C)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCn1cc[n+](C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1cc[n+](C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCn1cc[n+](C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCn1cc[n+](C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCn1cc[n+](C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[n+]1ccn(CCO)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCn1cc[n+](C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCn1cc[n+](C)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCn1cc[n+](C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCn1cc[n+](C)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCn1cc[n+](CCCCCCCCCC)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCn1cc[n+](C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1cc[n+](C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCn1cc[n+](C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)NC(=O)c1cc(Oc2ccc(C(F)(F)F)cc2Cl)ccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)Nc1ccc(Oc2ccc(Cl)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](Cc1ccc(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1ccccc1Oc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1cc(Oc2ccc(Cl)cc2Cl)ccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1cc(Br)c(Oc2cc(Br)c(Br)cc2Br)cc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1ccc(Oc2ccc(Br)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(Oc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(Oc2ccc([N+](=O)[O-])cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Oc2ccc(N)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)COC(=O)c1cc(Oc2ccc(C(F)(F)F)cc2Cl)ccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NNS(=O)(=O)c1ccc(Oc2ccc(S(=O)(=O)NN)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(Oc2ccc(Cl)cc2Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Oc2ccc(N)c(N)c2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AhR) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1ccc(Oc2ccc(S(N)(=O)=O)cc2CN(C)C)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1cc(Oc2cc(Br)c(Br)c(Br)c2Br)c(Br)c(Br)c1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 8 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCc1cccc(Oc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(Oc2ccc(C(F)(F)F)cc2[N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(Oc2ccc(N=C=S)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1ccc(Oc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(C)OC(=O)c1cc(Oc2ccc(C(F)(F)F)cc2Cl)ccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(Oc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(Oc2ccc(C(F)(F)F)cc2Cl)ccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1cccc(Oc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1ccc(Oc2ccc(Br)cc2Br)c(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Oc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1ccc(Oc2cc(Br)c(Br)cc2Br)c(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1cc(Oc2ccc(C(F)(F)F)cc2Cl)ccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccc(Oc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCc1cccc(Oc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCc1cc(F)ccc1Oc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)[C@@H](C)Oc1ccc(Oc2ccc(C#N)cc2F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Oc2ccc(Cl)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)NCCOc1ccc(Oc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C(C)Oc1ccc(Oc2ccc(Cl)cc2Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C=C1CC[C@H]1[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@]3(C)O)[C@@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC#C[C@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(OC(=O)CCCCCC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]2(C)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)O[C@]1(C(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H]3[C@@H](CCC4=C(Cl)C(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-Aromatase, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(=O)O[C@]1(C(=O)CO)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@@]1(O)[C@H](OC(C)=O)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(=O)OCC(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O[C@]1(C(=O)COC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12C=CC(=O)C=C1[C@@H](F)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1C[C@H]2C3C[C@H](F)C4=CC(=O)C=CC4(C)[C@@]3(F)[C@@H](O)CC2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)COC(=O)CCC(=O)O)[C@@]2(C)C=CC(=O)C=C12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC/C(C)=C/CC/C(C)=C/C(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)O[C@]1(C(=O)COC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(-c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCC(=O)c1ccc(-c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(-c2ccc(N)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccccc1-c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cccc(-c2cc(Cl)cc(Cl)c2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(-c2ccc(N)c(C)c2)ccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(-c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(-c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#Cc1ccc(-c2ccccc2F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCc1ccc(-c2ccc(C#N)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccccc1-c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(-c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccccc1-c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cc(Cl)c(-c2cc(Cl)c(Cl)cc2Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1cc(-c2ccc(Br)c(Br)c2Br)cc(Br)c1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(-c2ccccc2)cc1NNC(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(-c2ccc(N)c(OC)c2)ccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1ccc(-c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Fc1ccccc1-c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(-c2cc(C)c(N)c(C)c2)cc(C)c1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(-c2ccc(N=C=O)c(OC)c2)ccc1N=C=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccccc1-c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(Cl)c(-c2cc(Cl)c(N)cc2Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(-c2ccc(N)c(N)c2)cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(-c2ccc(O)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)Cc1ccc(-c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(OI)c(C(C)C)cc1-c1cc(C(C)C)c(OI)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(-c2ccc(N)c(Cl)c2)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AhR, NR-Aromatase, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(-c2ccc(F)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1cccc(-c2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1ccccc1-c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1ccc(-c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(-c2ccccc2C#N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(-c2ccc(C(C)(C)C)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1-c1ccc(C(F)(F)F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(-c2ccccc2)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-ER) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC(C)OC(=O)C(C)c1ccc(-c2ccccc2)c(F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC(O)CC(C)(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)[C@@H]1CC=C(C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(CC=O)C(C)(C)CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)/C=C/C1=C(C)CCCC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)/C=C/C1C(C)=CCCC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(C=O)C(C)(C)CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)CCCC1=CCC(C=O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. MODERATE-RISK: reactive aldehyde. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C=CC1=C(C)CCCC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)OC(C)(C)C1CC=C(C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)/C=C/C1C(C)=CCCC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)C1CC(C(C)C)CC=C1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC1CC=CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC(C)(C)C1CC=C(C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(/C=C/C(C)=C\\C=C/C(C)=C/C(=O)O)C(C)(C)CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)/C(C)=C/C1C(C)=CCCC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC[C@](C)(O)[C@@H]1CC=C(C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=O)C(C)(C)CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. MODERATE-RISK: reactive aldehyde. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(/C=C/C(C)=C/C=C/C(C)=C\\C=O)C(C)(C)CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. MODERATE-RISK: reactive aldehyde. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)/C=C/C1C(C)=CCC(C)C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)[C@@H]1CC=C(C=O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC(C)C(C=O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C1CC=C(C)C(OC(C)=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C1CC=C(C)C(O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)[C@H]1CC=C(C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CC1CC=CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(/C=C/C(C)=C/C=C\\C(C)=C\\C(=O)O)C(C)(C)CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC(=O)OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CCC(O)(C(C)C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC1CC=CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCCC(=O)/C=C/C1C(C)=CCCC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C1CC=C(C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CCC(C(C)(C)O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC(C)C(C=O)C(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC[C@@](C)(O)[C@H]1CC=C(C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CCC1=C(C)CCCC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccccc1)c1cc(Cl)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(C(=O)c2ccc(N(C)C)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD, NR-AhR) and cellular stress response (SR-ATAD5, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(CC(=O)O)cccc1C(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(=O)c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(=O)c2ccc(C)cc2)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccc(O)cc1)c1ccc(O)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Cl)cc1C(=O)c1ccccc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccc(O)c(O)c1)c1ccc(O)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER, NR-ER-LBD) and cellular stress response (SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(=O)c2ccc(OC)cc2O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccc(Cl)cc1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccc(O)cc1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccc(O)cc1)c1ccc(O)c(O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(O)c(C(=O)c2ccccc2)cc1S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccccc1)c1ccc(O)c(O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CBr)Nc1ccc(Cl)cc1C(=O)c1ccccc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)c1ccc(C(=O)c2ccccc2C(=O)O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(=O)c2ccccc2O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccccc1O)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(=O)c2ccccc2)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccccc1)c1ccc(O)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccc(O)cc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(=O)c2cccc(O)c2)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccccc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCCC)c1ccc(C(=O)c2ccccc2C(=O)O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1cc(O)c(O)c(O)c1)c1ccc(O)c(O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCOc1ccc(C(=O)c2ccccc2)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccc(O)cc1O)c1ccc(O)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-HSE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(O)c(C(=O)c2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccccc1)c1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccccc1)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(S(=O)(=O)O)c2cccnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2c(Br)cc(Br)c(O)c2n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ATAD5, SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(Cl)cc(Cl)c2cccnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ATAD5, SR-HSE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2c(Cl)cc(Cl)c(O)c2n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(Br)cc(Br)c2cccnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1ccc(O)c2ncccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2ccc(Cl)cc2n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1cc(I)c(O)c2ncccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc2ncccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(O)c2ncccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Cl)c2cccnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1c(Cl)ccc2cc(Cl)cnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2ccccc2n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc2ncccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cccc2cccnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccnc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cnc2c(C(=O)O)c(Cl)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(NC(C)CCCN)c2ncccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2cccnc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(I)cc(Cl)c2cccnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(NCCCC(C)N)c2ncccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cccc2cccnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-HSE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2ncccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC(C)OC(=O)COc1ccc(Cl)c2cccnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc2cccnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2ncccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(O)c2ncccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(I)cc(I)c2cccnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCOc1cc2c(O)c(C(=O)OCC)cnc2cc1OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc2ccccc2nc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1cnc2cc(OCC(C)C)c(OCC(C)C)cc2c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=NN(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Nc1ccc(Nc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)N(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Nc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccccc1Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(Nc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Nc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccccc1Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(Cl)cccc1Nc1ccccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(Nc2ccc(OC)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(Nc2ccccc2C(=O)O)ccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cccc(Nc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(C)Nc1ccc(Nc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OCCOCCO)c1ccccc1Nc1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(Nc2ccccc2C(=O)O)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Nc1ccc(Nc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)CC(C)(C)c1ccc(Nc2ccc(C(C)(C)CC(C)(C)C)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1Nc1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(C)N(c1ccccc1)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1Nc1cc(Cl)ccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(Nc2ccccc2)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(Nc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(C)Nc1ccc(Nc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(Nc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)Oc1ccc[n+](C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [O-][n+]1ccccc1S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC[n+]1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC[n+]1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[n+]1cccc(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC[n+]1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[n+]1ccccc1/C=N/O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[n+]1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[n+]1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[n+]1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc[n+]([O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc[n+]1[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[n+]1ccccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc[n+]([O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCC[n+]1ccc(C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [O-][n+]1cccc(CO)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [O-][n+]1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(C)n(CCN(C)C)c2ccc(C(=O)OCCN(C)C)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)c1cc2c(OCC(O)CNC(C)(C)C)cccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCC)CCc1c[nH]c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCc1c[nH]c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2[nH]cc(CCN(C(C)C)C(C)C)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCc1c[nH]c2cccc(OP(=O)(O)O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@H](Cc1c[nH]c2ccccc12)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(N)Cc1c[nH]c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1c(C)n(C)c2ccc(O)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC(O)COc1cccc2[nH]ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(=O)NO)CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2[nH]cc(CCNC(C)=O)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cccc2[nH]ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c[nH]c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cccc2c(CCO)c[nH]c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1c[nH]c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2[nH]ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(=O)Cc1c[nH]c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(Cc1c[nH]c2ccccc12)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C(CN)c1c[nH]c2ccc(OC)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCc1c[nH]c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCc1c[nH]c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1nc(Cl)nc(NC(C)(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1nc(O)nc(O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCN(COC)c1nc(N(COC)COC)nc(N(COC)COC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOc1nc(OCC=C)nc(OCC=C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1nc(NC(C)(C)C)nc(SC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc(N)nc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1nc(C)nc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1nc(NC(C)C)nc(NC(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1nc(N=[N+]=[N-])nc(NC(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1nc(NC(C)C)nc(SC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(N)nc(Cl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1nc(NC(C)C)nc(NC(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Nc1nc(Cl)nc(NC(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1nc(NC(C)CC)nc(OC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1nc(NCC)nc(SC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(N)nc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1nc(Cl)nc(Cl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1nc(Cl)nc(NCC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Nc1nc(N)nc(Cl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1nc(N)nc(Cl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1nc(NC(C)C)nc(OC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1nc(NC(C)C(C)C)nc(SC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1nc(Cl)nc(NC(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1nc(N(C)C)nc(N(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1nc(Cl)nc(NC(C)(C)C#N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1nc(O)nc(O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCc1ccco1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)SCc1ccco1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)C(CC)Sc1ccoc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccco1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccoc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccco1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1occc1S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CSSc1ccoc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CNC(=O)c1ccc(CO)o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C)o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCc1ccco1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCc1ccco1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN/C(=C\\[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1cc(C)oc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)SCc1ccco1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccc(CO)o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)C(=O)NN=Cc1ccc([N+](=O)[O-])o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N/N=C/c1ccc([N+](=O)[O-])o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccco1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(C=NO)o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C=Cc1ccco1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(=O)O)o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)N/N=C/c1ccc([N+](=O)[O-])o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC(OC(C)=O)c1ccc([N+](=O)[O-])o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-ATAD5, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C/C=C/c1ccco1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(CO)o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2c(O)ccc([N+](=O)[O-])c2C(=O)c2c([N+](=O)[O-])ccc(O)c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2cccc(O)c2C(=O)c2c(O)cc(CO)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc2c(c1)C(=O)c1ccccc1C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)c2cc(O)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(S(=O)(=O)O)cc(Br)c2c1C(=O)c1ccccc1C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2c(c1N)C(=O)c1ccccc1C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(Br)cc(Br)c2c1C(=O)c1ccccc1C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2cccc(O)c2C(=O)c2c(O)cccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(N)c2c1C(=O)c1ccccc1C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Nc1ccc(NC(C)C)c2c1C(=O)c1ccccc1C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)c2cc(Cl)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)c2c(O)c(O)cc(O)c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)c2cc(S(=O)(=O)O)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2c(c1[N+](=O)[O-])C(=O)c1ccccc1C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc2c(c1)C(=O)c1ccccc1C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-ATAD5, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)c2c(O)ccc(O)c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2c(c1)C(=O)c1ccccc1C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)c2c1ccc(O)c2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C(F)(C(F)(F)F)C(F)(F)F)ccc1NC(=O)c1cccc(I)c1C(=O)NC(C)(C)CS(C)(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 8 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(I)cc(I)c(C(=O)N(CCC(=O)O)c2ccccc2)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccccc1)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(NC(=O)c2ccc(N)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1C(=O)Nc1cccc(OC(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCOc1ccccc1C(=O)Nc1ccc(C(=O)OCC[N+](C)(CC)CC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Oc1cccc(NC(=O)c2ccccc2C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccccc1)c1cc([N+](=O)[O-])ccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1cccc(C(F)(F)F)c1)c1cc(Br)cc(Br)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-HSE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Oc1ccccc1C(=O)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccccc1)c1cc(Cl)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-HSE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc(C(=O)O)c(O)c1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc(O)cc1)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1NC(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccccc1)c1ccccc1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)C(C)N(C(=O)c1ccccc1)c1ccc(F)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(=O)Nc2ccccc2)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(C(=O)Nc2ccccc2N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AhR, NR-ER, NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1NC(=O)c1ccccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1NC(=O)c1cc(S(N)(=O)=O)c(Cl)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[Si](C)(CCCOCC1CO1)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCOCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1O[C@@H]1P(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)OCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[Si](CCCOCC1CO1)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(C)CC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCOCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@]1(O)OC[C@@H](O)[C@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1OC([S][Au])[C@H](O)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCO[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(N=O)C(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[P](CC)(CC)=[Au][S][C@H]1O[C@@H](COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC1OC[C@@H](O)[C@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOC[C@H]1O[C@@H](O)[C@H](OCCN(CC)CC)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC1OC[C@@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc2nc(S(N)(=O)=O)sc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc2ccccc2s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOc1ccc2nc(N(C)C)sc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc2nc(N)sc2cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc2c(Cl)cccc2s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)N(C)c1nc2ccccc2s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc2ccc([N+](=O)[O-])cc2s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CSCSc1nc2ccccc2s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-HSE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc2ccc(OC(F)(F)F)cc2s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Sc1nc2ccccc2s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2scnc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc2ccccc2s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1nc2ccccc2s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc2sc(N)nc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc2sc(N)nc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2nc(N)sc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc2nc(N)sc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOc1ccc2nc(NC(=O)OC)sc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NSc1nc2ccccc2s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(Cl)cc(Cl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)OCC/C(SC(=O)OCC)=C(\\C)N(C=O)Cc1cnc(C)nc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)Oc1cc(C)nc(C(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCSSC(CCO)=C(C)N(C=O)Cc1cnc(C)nc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)Oc1cc(C)nc(N(CC)CC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cc(Cl)nc(Cl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccnc(Cl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1cc(OP(=S)(OC)OC)nc(CC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(Oc1cnc(C(C)(C)C)nc1)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CCCCC(CCSS/C(CCO)=C(\\C)N(C=O)Cc1cnc(C)nc1N)SC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1c(C)nc(NCC)nc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(O)nc(O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1c(C)nc(NCC)nc1OS(=O)(=O)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc(N(C)C)nc(OC(=O)N(C)C)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(OCC)Oc1cc(C)nc(C(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)c1nc(C)cc(OP(=S)(OC)OC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(N)c(N)c(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc([N+](=O)[O-])n1CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](Cc1cnc[nH]1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCc1cnc[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN/C(=N\\C#N)NCCSCc1nc[nH]c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc([N+](=O)[O-])n1CC(O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)N=Nc1nc[nH]c1C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)/C=C/c1c[nH]cn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc([N+](=O)[O-])n1CC(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1nc(C)c[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c[nH]cn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1c([N+](=O)[O-])cnc1COC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1nccn1CO[C@@H](CO)[C@H](O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cn1ccnc1[N+](=O)[O-])NCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc([N+](=O)[O-])n1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1c[nH]cn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ncc([N+](=O)[O-])n1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncsc1CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cscn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(=O)c1csc(NC=O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C(\\C(=O)O)c1csc(NC(=O)CCl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN/C(=N\\[N+](=O)[O-])NCc1cnc(Cl)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(N)=Nc1nc(CSCC/C(N)=N\\S(N)(=O)=O)cs1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Cc1nccs1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(CC(=O)O)cs1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nccs1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1nccs1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ncc([N+](=O)[O-])s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ncc([N+](=O)[O-])s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN/C(=N\\C#N)NCCSCc1csc(N=C(N)N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncsc1CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1ncc(C(=O)O)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1sc(C)nc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2OP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2OP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-ER, NR-ER-LBD) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-Aromatase, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-HSE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)C(OC)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1C[C@@H](OC(=O)CC)[C@@H]2OC(=O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OC(=O)CC)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=Cc1ccc2c(c1)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(N)Cc1ccc2c(c1)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCc1ccc2c(c1)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCc1cc(OC)c2c(c1)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Oc1cccc2c1OC(C)(C)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CCc1ccc2c(c1)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc2c(c1)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(CC(C)N)cc2c1OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cc1ccc2c(c1)OCO2)NO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNC(C)Cc1ccc2c(c1)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(C)Cc1ccc2c(c1)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C=O)Cc1ccc2c(c1)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCS(=O)C(C)Cc1ccc2c(c1)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOCCOCCOCc1cc2c(cc1CCC)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C=Cc1ccc2c(c1)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1ccc2c(c1)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCc1ccc2c(c1)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)OC(=O)N1CCCCC1CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCC1CCCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC1CCCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CC(O)CC(C)(C)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNC1CC(C)(C)NC(C)(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(C)(C)CC(O)CC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CC(O)CC(C)(C)N1[O] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=NN1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCCNC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1CCC[C@H](C)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CN1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CC(N)CC(C)(C)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(C)(C)CCCC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1cnc2c1c(=O)[nH]c(=O)n2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1c(=O)c2[nH]c(Br)nc2n(C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1c(=O)c2c(ncn2CC(=O)O)n(C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1c(=O)c2[nH]cnc2n(C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1c(=O)c2c(ncn2CCO)n(C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)Cn1cnc2c1c(=O)n(C)c(=O)n2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1c(=O)c2c(ncn2C)n(C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Cn1cnc2c1c(=O)n(C)c(=O)n2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCn1cnc2c1c(=O)n(CCCCC(C)=O)c(=O)n2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCn1c(=O)[nH]c(=O)c2[nH]cnc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CN1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CO[C@@H](CC(=O)O)CN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=NN1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NC(=N)N1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)CCCN1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCN1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCN1CC(C)OC(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)N1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCN1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCN1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCN1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1COCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc2c(c1)Nc1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCN1c2ccccc2Sc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCC(=O)N1c2ccccc2Sc2ccc(Cl)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CN1c2ccccc2Sc2ccccc21)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CN1c2ccccc2Sc2ccc(S(=O)(=O)N(C)C)cc21)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc2c(c1)N(CC(C)CN(C)C)c1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCC(=O)N1c2ccccc2Sc2ccc(C(F)(F)F)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)Nc1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(/N=N/c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(/N=N/c2ccc(N(C)C)cc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(N=Nc2ccc(N)cc2N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AhR, NR-ER) and cellular stress response (SR-ATAD5, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(/N=N\\c2ccccc2)c(N)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(/N=N/c2ccccc2C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CCC#N)c1ccc(N=Nc2c(Cl)cc([N+](=O)[O-])cc2Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(N=Nc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(N=Nc2ccccc2C)ccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(/N=N/c2ccc([N+](=O)[O-])cc2)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCCN(CCOC(C)=O)c1ccc(/N=N/c2ccc([N+](=O)[O-])cc2C#N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(/N=N/c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(/N=N/c2ccc(N)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(N=Nc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCc1ccc(OCC(O)CNC(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/N=C(\\NC)NCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(C)(C)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNc1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [2H]C([2H])([2H])[C@H](N)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NCC(O)c1cc(O)cc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC(O)c1cc(O)cc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NCc1cccc(I)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CC[C@@H](C(=O)O)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CN1CCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)CN1CCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(O)/C=C(C)/C=C/C=C/C(=O)N1CCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCN1CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C(N)=O)N1CCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCN1CCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CN1CCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCN1CCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)CN1CC(O)CC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc2ccccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5, SR-HSE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2[nH]cnc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc2ccc(Cl)cc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)Nc1nc2ccccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOc1ccc2[nH]c(NC(=O)OC)nc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-ATAD5, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNC(=O)n1c(NC(=O)OC)nc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1c(CCCC(=O)O)nc2cc(N(CCCl)CCCl)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCc1nc2ccccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCS(=O)c1ccc2[nH]c(NC(=O)OC)nc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc2[nH]cnc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AhR, NR-ER) and cellular stress response (SR-ATAD5, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)Nc1nc2ccccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1/C=C/Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)c(=O)[nH]c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cn([C@H]2C[C@H](F)[C@@H](CO)O2)c(=O)[nH]c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c(=O)n([C@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)cc1/C=C\\Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c(=O)n(C2CCCO2)cc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C/CCCCCCCC(=O)OCCOCC(OCCO)C1OC(OCCO)CC1OCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC[C@H]1O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC1CCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCC1CCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC/C=C\\CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(O)OC[C@H]1O[C@](O)(COP(=O)(O)O)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCC1CCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCOC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](OCCO)[C@H]1OCCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN/C(=N/[N+](=O)[O-])NCC1CCOC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. HIGH-RISK FEATURES: nitro group (potential mutagenicity). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER, NR-PPAR-gamma) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCCCC1(C(N)=O)c2ccccc2-c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc2c(c1)Cc1ccccc1-2)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc2c(c1)Cc1ccccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C1(O)c2ccccc2-c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc2c(c1)Cc1ccccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc2c(c1)-c1ccccc1C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)Cc1ccccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc2c(c1)Cc1cc(NC(C)=O)ccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc2c(c1)Cc1ccccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AhR, NR-ER) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc2c(c1)Cc1ccccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC1(C)CCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC1CCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC1CCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCC1CCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C1CCOC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC1CCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1CCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC1CCOC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC1CCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC1CCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1O[C@@H](n2cnc3c(S)ncnc32)[C@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ncnc2c1ncn2[C@H]1CC[C@@H](CO)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1O[C@@H](n2cnc3c(O)ncnc32)[C@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O)C(O)C(=O)NCCC(=O)NCCS for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C1CCC(=O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CC(=O)CC(C)(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCC(C(C)(C)S)C(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC1CCC(=O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[C@H]1CC[C@@H](C)CC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C1CCCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)C1CCCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)C1CCC(=O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[C@@H]1CC[C@@H](C)CC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C1CCCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCCC1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NC(=O)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)c2ccccc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)N1CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)c2ccc([N+](=O)[O-])cc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN1C(=O)c2ccccc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NC(=O)c2cc([N+](=O)[O-])ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)N1SC(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)SC(CCl)N1C(=O)c2ccccc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(OC)SCN1C(=O)c2ccccc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)N1C(=O)c2ccccc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)N1CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@@H]1C[C@H]2CC[C@]1(C)C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@@H]2CC[C@@]1(C)[C@H](O)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O[C@@H]1C[C@H]2CC[C@]1(C)C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC1C2(C)CCC(C2)C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC1(C)C2CCC(C2)C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@@H]1CC2CCC1(C)C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@H]2CC[C@]1(C)[C@H](O)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@H]2CC[C@](C)(C2)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)O[C@@H]1C[C@H]2CC[C@]1(C)C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC12CCC(C1)C(C)(C)C2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@@H]2CC[C@@]1(C)[C@H](OC(=O)CSC#N)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CNCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=NN1CCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)CCN1CCN(CCO)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCN1CCN(CCCN)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCN1CCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCN1CCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCBr)N1CCN(C(=O)CCBr)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar monocyclic system. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(N)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCN1CCN(CCO)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)N1CCN(C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=NN1CCN(N=O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Cl)cc1Sc1cc(Cl)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(Sc2ccc(N)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)c(C(C)(C)C)cc1Sc1cc(C(C)(C)C)c(O)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Sc2ccc(O)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(Sc2cc(Cl)c(Cl)cc2Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(Sc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NCc1ccccc1Sc1ccccc1CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCC(=O)Nc1cc(Sc2ccccc2)ccc1N=C(NC(=O)OC)NC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+]1(C)CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[N+]1(C)CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[N+]1(C)CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc2cc3ccccc3cc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1c2ccccc2cc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-PPAR-gamma) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)c2c(O)c3c(O)cccc3cc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1c2ccccc2cc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc2cc3ccccc3cc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1c2ccccc2cc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1c2ccccc2c(Cl)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: reactive aldehyde, 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cccc2cc3cccc(O)c3c(O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1c2ccccc2c(Br)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCc1c2ccccc2cc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2cc3ccccc3cc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C1=C(C)NC(COC(N)=O)=C(C(=O)OC(C)C)C1c1cccc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)=O)C1c1ccccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1OC(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(=O)oc2cc(O)cc(O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)c1ccc2c(C)cc(=O)oc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AhR) and cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(Cl)c(=O)oc2cc(OP(=O)(OCCCl)OCCCl)ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1ccc2ccccc2o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)Oc1ccc2c(C)c(Cl)c(=O)oc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(OC)c2ccc(=O)oc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(=O)oc2cc(N(C)C)ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-ATAD5, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)COc1ccc2c(C)c(CCN(CC)CC)c(=O)oc2c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(=O)oc2cc(O)ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) and cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CCOc1ccc2c(C)cc(=O)oc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2oc(=O)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C(=C/c1ccccc1)\\c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(C=Cc2ccc([N+](=O)[O-])cc2S(=O)(=O)O)c(S(=O)(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C(=C(/CC)c1ccc(OP(=O)(O)O)cc1)c1ccc(OP(=O)(O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=C(CC)c1ccc(O)cc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+](CC)(CC)CCOc1ccc(/C=C/c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(C=Cc2ccc(N)cc2S(=O)(=O)O)c(S(=O)(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C(=C\\c1ccccc1)\\c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)Oc1ccc(/C(CC)=C(\\CC)c2ccc(OC(=O)CC)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(/C=C/c2ccc([N+](=O)[O-])cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc(C)c(C)nc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cnc(C)c(C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1nccnc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1nc(Cl)c(Cl)nc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cnccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1cnccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NC(=O)c1nc(Cl)c(N)nc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)c1nccnc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1nccnc1CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1cnccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1cnccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(c1ccccc1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(c1ccc(Cl)cc1)c1cc(Cl)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(c1ccc(O)cc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cccc(S(=O)(=O)c2cccc(N)c2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccccc1S(=O)(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(c1ccc(Cl)cc1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCc1cc(S(=O)(=O)c2ccc(O)c(CC=C)c2)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(O)CNc1ccc(S(=O)(=O)c2ccc(NCS(=O)O)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(OC(=O)c2ccccc2O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(OC(=O)c2ccccc2O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(OC(=O)c2ccccc2OC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Oc1ccccc1C(=O)O)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(OC(=O)c2ccccc2O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(C(=O)Oc2ccccc2)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Oc1ccccc1)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR) and cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Oc1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Oc1ccccc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)OC(=O)N1C[C@@H](F)C[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C1CCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCCN1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)[C@H]1CN[C@H](C(=O)O)[C@H]1CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N1C[C@H](O)C[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCCC1CN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=NN1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@]12CCC[C@H]1[C@@H]1CC[C@H]3C[C@@H](O)CC[C@]3(C)[C@H]1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[N+]1(C)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[N+]1(C)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1(C)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CC1C(C(=O)OC(C#N)c2cccc(Oc3ccccc3)c2)C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@H](C(=O)O[C@H](C#N)c2cccc(Oc3ccccc3)c2)[C@@H]1C=C(Br)Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@H](C(=O)O[C@H](C#N)c2cccc(Oc3ccccc3)c2)[C@@H]1/C=C(\\Cl)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@H](C=C(Cl)Cl)[C@@H]1C(=O)O[C@@H](C#N)c1cccc(Oc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C(C(=O)OC(C#N)c2cccc(Oc3ccccc3)c2)C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@H](/C=C(\\Cl)C(F)(F)F)[C@@H]1C(=O)O[C@H](C#N)c1cccc(Oc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(S(=O)(=O)O)ccc1/N=N/c1c(O)ccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc2ccccc2c1/N=N/c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)c(/N=N/c2c(O)c(S(=O)(=O)O)cc3cc(S(=O)(=O)O)ccc23)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(S(=O)(=O)O)c(C)cc1/N=N/c1c(O)ccc2cc(S(=O)(=O)O)ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(/N=N/c2c(O)c(C(=O)O)cc3ccccc23)c(S(=O)(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1ccc(/N=N/c2c(O)ccc3cc(S(=O)(=O)O)ccc23)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1cc(S(=O)(=O)O)c2c(/N=N/c3ccccc3)c(O)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc2cc(S(=O)(=O)O)cc(O)c2c1/N=N/c1ccccc1C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1ccc(N=Nc2c(O)ccc3ccccc23)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C(N(CO)C(=O)NCO)N(CO)C(=O)N1CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C(=O)N(Cl)C(=O)N1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C(=O)N(Br)C(=O)N1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)NC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C(=O)N(Br)C(=O)N1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C(=O)N(Cl)C(=O)N1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)NC1NC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C(=O)NC(=O)N1CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(C)NC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCC1([C@H](C)CCC)C(=O)NC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCC1([C@@H](C)CCC)C(=O)NC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(CC)C(=O)NC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(CC)C(=O)NC(=O)N(C)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CC(=O)NC(=O)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCC1(C(C)CC)C(=O)NC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(CCC(C)C)C(=O)NC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C(=O)NC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C1CC=C(C)C(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC(=O)CC(C)(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=NOCC)C1=C(O)CC(CC(C)SCC)CC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC(=O)CC(C)(C)C1(O)/C=C/C(C)=C\\C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)[C@@H]1CC=C(C)C(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C=CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)[C@H]1CC=C(C)C(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC(=O)CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(CCl)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NCNS2(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1Nc2cc(Cl)c(S(N)(=O)=O)cc2S(=O)(=O)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC1Nc2cc(C(F)(F)F)c(S(N)(=O)=O)cc2S(=O)(=O)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCSCC1Nc2cc(Cl)c(S(N)(=O)=O)cc2S(=O)(=O)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) and cellular stress response (SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(Cl)=C(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C(=C(c1ccccc1)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C(=C(\\c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C(=C(\\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase, NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\\CCCC(=O)O)[C@@H](O)C[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1CCC(CCC(=O)O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC(=O)CC[C@@H]1[C@@H](C/C=C\\CCCC(=O)OC(C)C)[C@@H](O)C[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule SC1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1cc(-c2ccccc2)oc2cc(O)cc(O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1cc(-c2ccccc2)oc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(=O)c(C)c(-c3ccccc3)oc2c1CN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)COc1ccc2c(=O)cc(-c3ccccc3)oc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(C)C(=O)C(CCCCC#CCCCC#CCO)=C(C)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC1=C(OC)C(=O)C(C/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C)=C(C)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. Structural analysis reveals these structural features that correlate with cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C(Cl)=C(Cl)C(=O)C(Cl)=C1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER-LBD) and cellular stress response (SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C1=CC(=O)C=C(C(C)(C)C)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C=CC(=O)C=C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C(O)=C(O)C(=O)C(O)=C1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1/C(=C\\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)OCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings. these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1CC[C@H](O)C/C1=C/C=C1\\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1/C(=C\\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1/C(=C\\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1CC[C@H](O)C/C1=C/C=C1\\CCC[C@]2(C)[C@@H]([C@H](C)CC[C@@H](O)C(C)(C)O)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings. Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1CC[C@H](O)C/C1=C/C=C1\\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings. The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1CC[C@H](O)C/C1=C/C=C1\\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=NN(c2ccc(S(=O)(=O)O)cc2)C(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C1=NN(c2ccc(S(=O)(=O)O)cc2)C(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=NN(c2ccccc2)C(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=NN(c2cccc(S(=O)(=O)O)c2)C(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C1=NN(c2ccccc2)C(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccccc1N1CCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(N2CCNCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1N1CCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(O)CN1CCN(c2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cccc(N2CCNCC2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClCCCN1CCN(c2cccc(Cl)c2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N1CCN(c2ccc(O)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(C(C)C)c(=O)n(-c2ccccc2)n1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(=O)n(-c2ccccc2)n1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(I)c(=O)n(-c2ccccc2)n1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(N)c(=O)n(-c2ccccc2)n1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(NC(C)C)c(=O)n(-c2ccccc2)n1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(N(C)C)c(=O)n(-c2ccccc2)n1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)C[C@@H](N)C(=O)N[C@@H](C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)S[C@@H]2[C@H](NC(=O)[C@@H](c3ccccc3)S(=O)(=O)O)C(=O)N2[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(O)C(=O)OC1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1O[C@H]([C@H](O)CO)C(O)=C1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1O[C@H]([C@@H](O)CO)C(O)=C1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC(O)C(C(Cl)Cl)=C1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@H](O)[C@H]3C[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4C[C@H]3C[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)[C@@H]1C(O)=C(C(=O)NCN[C@@H](CCCCN)C(=O)O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)C3C[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCC(C)N(C(=O)CCl)c1c(C)csc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1sc(Cl)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1sccc1S(N)(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccsc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C=O)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1sccc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2c(ccc3ccccc32)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1cc2ccccc2c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)ccc1ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cc2ccccc2c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc2ccc3ccccc3c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1cc2ccccc2c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc(C(F)(F)F)c(Cl)c([N+](=O)[O-])c1Nc1ncc(C(F)(F)F)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 8 halogen atom(s) (potential bioaccumulation), aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(Nc2ncccc2C(=O)O)cccc1C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(Nc2ncccc2C(=O)O)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1Nc1ncccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ATAD5, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(Cl)cccc1Nc1ncccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCN1C[C@H](C)N([C@H](c2ccc(C(=O)N(CC)CC)cc2)c2cccc(OC)c2)C[C@H]1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(C(c2ccccc2)c2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCCCCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)cc1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC(=O)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC(=O)c2c(Cl)c(Cl)c(Cl)c(Cl)c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC(=O)c2c(Br)c(Br)c(Br)c(Br)c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2c(c1)C(=O)OC2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc2c(c1)C(=O)OC2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC(=O)c2cc([N+](=O)[O-])ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cc1ccccc1)(NC(=O)CN)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](c1ccc(O)cc1)[C@@H](CC)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(CCc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(Cc1cc(I)c(O)c(I)c1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=CC=C(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: reactive aldehyde. these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(C(=C(Cl)Cl)c2ccc(O)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(C#N)=C(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC(Cl)=C(c1ccc(Cl)cc1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COC(=O)C(C#N)=C(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(CN)=C(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 3 rings. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC[C@@H]1CC[C@@H](N)[C@@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](N)C[C@H]2NC(=O)C(O)CN)OC[C@]1(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 3 rings. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1CN(c2c(F)c(F)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC2(c3cc(Br)c(O)c(Br)c3Oc3c2cc(Br)c(O)c3Br)c2c(Cl)c(Cl)c(Cl)c(Cl)c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 8 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC2(c3cc(Br)c(O)cc3Oc3c2cc(Br)c(O)[c]3[Hg][OH])c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC2(c3ccccc31)c1cc(Br)c(O)c(Br)c1Oc1c2cc(Br)c(O)c1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC2(c3ccccc31)c1cc(I)c(O)c(I)c1Oc1c2cc(I)c(O)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)n1c(=O)[nH]c(C)c(Br)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1[nH]c(=O)n(C(C)(C)C)c(=O)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1cc[nH]c(=O)[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]cc(F)c(=O)[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1c(N)c(N=O)c(=O)n(C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc(NS(=O)(=O)c2ccc(N)cc2)nc(C)c1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2cnncc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1nnc(Cl)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cccc2c(O)nnc(O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NNc1nnc(NN)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NNc1nncc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)NNc1nncc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)N(c1ccccc1)C1CCN(CC(O)c2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)N(c1ccccc1)[C@@H]1CCN(CCc2ccccc2)C[C@@H]1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)N(c1ccccc1)[C@H]1CCN(CCc2ccccc2)C[C@@H]1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)N(c1ccc(F)cc1)C1CCN(CCc2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)N(c1ccccc1)C1CCN(C(C)Cc2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)cc(OP(=O)(Oc2cc(C)cc(C)c2)Oc2cc(C)cc(C)c2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(OP(=O)(Oc2ccccc2)Oc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(OP(=O)(Oc2ccc(C)cc2)Oc2ccc(C)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(OP(=O)(Oc2ccccc2)Oc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1OP(=O)(Oc1ccccc1C)Oc1ccccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(Oc1ccccc1)(Oc1ccccc1)Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1n(CCO)c(=O)n(CCO)c(=O)n1CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCCn1c(=O)n(CCOC(=O)C=C)c(=O)n(CCOC(=O)C=C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c(=O)n(Cl)c(=O)n1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[Si](CCCn1c(=O)n(CCC[Si](OC)(OC)OC)c(=O)n(CCC[Si](OC)(OC)OC)c1=O)(OC)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1n(Cl)c(=O)n(Cl)c(=O)n1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCn1c(=O)n(CC=C)c(=O)n(CC=C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN(CCCC)SN(C)C(=O)Oc1cccc2c1OC(C)(C)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)Cc2cccc(O)c2O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Oc1cccc2c1OC(C)(C)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC1Oc2ccc(OS(C)(=O)=O)cc2C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)Cc2cccc(N)c2O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CCN(SN(C)C(=O)Oc1cccc2c1OC(C)(C)C2)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)N(CCC(C(N)=O)(c1ccccc1)c1ccccn1)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCOC(C)(c1ccccc1)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCC=CC1CC(=O)OC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC=CCC1CC(=O)OC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCC/C=C/CC1CC(=O)OC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC/C=C/C1CC(=O)OC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(=C\\C(C)CC(C)CC(C)C)C1CC(=O)OC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCN1c2ccccc2CCc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCCCN1c2ccccc2CCc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CN(C)C)CN1c2ccccc2CCc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)Nc1ccc2c(c1)N(C(=O)CN(C)C)c1ccccc1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)CCc1ccccc1N2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NC(=O)c1c(F)cccc1F)Nc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NC(=O)c1c(F)cccc1F)Nc1cc(Cl)c(OC(F)(F)C(F)C(F)(F)F)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 10 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NC(=O)c1ccccc1Cl)Nc1ccc(OC(F)(F)F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NC(=O)c1c(F)cccc1F)Nc1cc(Cl)c(F)c(Cl)c1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NC(=O)c1c(F)cccc1F)Nc1ccc(OC(F)(F)C(F)OC(F)(F)F)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 9 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)N[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@@H]2N(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC1CC(C)OC(C)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(CO)COCOC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC1(CO)COCOC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC1(CO)COC(C(Cl)(Cl)Cl)OC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])C1(Br)COCOC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc([N+](=O)[O-])cc1)Nc1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(C(=O)N(CC)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc(Cl)cc1)Nc1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccccc1)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C(Cl)=C(Cl)C(=O)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(C/C=C(\\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=O)c2ccccc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC(=O)c2ccccc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC1=C(O)C(=O)c2ccccc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=C(C)C(=O)c2ccccc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(NS(=O)(=O)c2ccc(N)cc2)ncn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 5 rings containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR) and cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 5 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 5 rings containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 5 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)NCC[C@@]341 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 5 rings containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)OCOC(=O)C(C)(C)C)=C(C)CS[C@H]12)c1csc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N/O)c3csc(N)n3)[C@H]2SC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N/OCC(=O)O)c3csc(N)n3)[C@H]2SC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=CCS[C@H]12)c1csc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC1CCCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC1CCCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC1CCCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-Aromatase, NR-ER, NR-ER-LBD) and cellular stress response (SR-ATAD5, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(O)cccc1C3=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-Aromatase, NR-ER-LBD) and cellular stress response (SR-ATAD5, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-Aromatase, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(=O)OCC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O2)C1)C(=O)c1c(OC)cccc1C3=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD) and cellular stress response (SR-ATAD5, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-Aromatase, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[PH](Oc1ccccc1)Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCCCCCCOP(=O)(Oc1ccccc1)Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(Cl)(Oc1ccccc1)Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)COP(=O)(Oc1ccccc1)Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(Oc1ccccc1)Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1nnc(NS(=O)(=O)c2ccccc2)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(S(=O)(=O)Nc2nnc(CC(C)C)s2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1nnc(NS(=O)(=O)c2ccc(N)cc2)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C=C1C=C[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]2(O)CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-ARE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1ccc(CC(=O)c2cccc(C(F)(F)F)c2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(OC)(C(=O)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cc1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccccc1)C(O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC(C(=O)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)C(F)(F)OCC(Cn1cncn1)c1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(C#N)(Cn1cncn1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(Cn1cncn1)c1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(O)(Cn1cncn1)c1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(O)C(Cc1ccc(Cl)cc1)n1cncn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OCc1ccccc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ATAD5, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1C(=O)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OCc1ccccc1)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)c1ccccc1C(=O)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OCc1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)[C@@H](C)Oc1ccc(Oc2ccc(C(F)(F)F)cn2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C(C)Oc1ccc(Oc2ncc(C(F)(F)F)cc2Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Oc1ccc(Oc2ncc(C(F)(F)F)cc2Cl)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)C(C)Oc1ccc(Oc2ccc(C(F)(F)F)cn2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CCOC(=O)[C@@H](C)Oc1ccc(Oc2ncc(Cl)cc2F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNc1ncnc2[nH]cnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ncnc2[nH]cnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC1CCCc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1cc2c(cc1C)C(C)(C)C(C)CC2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 1 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc2c(c1)CCCC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)CCCC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOC(=O)C(c1ccccc1)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)C(C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C(/C(=O)OC)c1ccccc1COc1ccccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(OCc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCCC(Oc1ccccc1OC)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCC[C@@H](Oc1ccccc1C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)OC1(c2ccccc2)CCN(C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC1(c2ccc(Cl)cc2)CCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC1(c2ccccc2)CCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@H]1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc(C2CCNCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)cc2c1O[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1c(C)c(C)c2c(c1C)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(C)c2c(c(C)c1OC(=O)CCC(=O)OCCO)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(C)c2c(c(C)c1OC(=O)CCC(=O)O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S1(=O)OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(C2(c3cc(Br)c(O)c(Br)c3C)OS(=O)(=O)c3ccccc32)cc(Br)c(O)c1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C2(c3cc(C)c(O)cc3C)OS(=O)(=O)c3ccccc32)c(C)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S1(=O)OC(c2cc(Br)c(O)c(Br)c2)(c2cc(Br)c(O)c(Br)c2)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\\CCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC1C(=O)CCC1CC(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCC1CCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(-c2coc3cc(O)ccc3c2=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(OC(=O)N(C)C)nn1C(=O)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)n(CO)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCc1cc[nH]n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)n1cccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cn[nH]c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)c1cc(Cl)cc(Cl)c1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)cc(C(=O)OC2C[C@H]3CC[C@@H](C2)N3C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1[C@H]2CC[C@@H]1[C@@H](C(=O)O)[C@@H](OC(=O)c1ccccc1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@@H]1[C@H]2CC[C@@H](C[C@H]1OC(=O)c1ccccc1)N2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O[C@@H]1C=C2CCC3C(CCC4(C)C3CC[C@@H]4OC(=O)CC)C2CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-Aromatase, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCN1CCC(O)(c2cccc(C(F)(F)F)c2)CC1)c1ccc(F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCN1CCC(O)(c2ccc(Br)cc2)CC1)c1ccc(F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3C[C@@H](O)[C@]3(C)[C@@H](C5=CC(=O)OC5)CC[C@]43O)C2)C[C@H](O)[C@@H]1O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](C)O2)[C@@H](C)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 9 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 9 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](OC4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 9 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H]1C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](OC4CC[C@@]5(C)C(CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)[C@@H](O)C[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)O[C@H](C)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 9 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1c(OCCCOc2ccc(OCC(=O)O)cc2)ccc(C(C)=O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(OCCCOc2ccc(C(=O)O)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2Br)c(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1C(C)(C)[C@@]2(Cl)C(Cl)[C@]1(Cl)C(Cl)(Cl)C2(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework. MODERATE-RISK: 7 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)/C=C/C=C1/C2CCC(C2)C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1C2CCC(C2)C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1C(CCl)(CCl)C2(Cl)C(Cl)C(Cl)C1(Cl)C2(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework. MODERATE-RISK: 8 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2[nH]nnc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule On1nnc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc2[nH]nnc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc2[nH]nnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)/C=C/c1ccc(Cn2ccnc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1cncn1C(C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1cncn1C(C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(=O)c1cncn1C(C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C)C1(CC)C(=O)N=C(O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(CC)C(=O)N=C(O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C)C1(CC)C(=O)N=C(S)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCC1(C(C)CCC)C(=O)N=C(S)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1cc(C(C)(C)C)cc2c1CCC2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c([N+](=O)[O-])cc2c(c1[N+](=O)[O-])C(C)(C)CC2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Cl)c2c1CCC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CCN[C@@H]1CCc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H]([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@@H]1SC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar bicyclic framework. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2ccc(S(=O)(=O)O)cc2S(=O)(=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD, NR-AhR, NR-Aromatase, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(S(=O)(=O)O)ccc2S(=O)(=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1nc(C)nc(NC(=O)NS(=O)(=O)c2ccccc2Cl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccccc1S(=O)(=O)NC(=O)Nc1nc(C)nc(OC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccccc1S(=O)(=O)NC(=O)N(C)c1nc(C)nc(OC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1nc(C)nc(NC(=O)NS(=O)(=O)c2ccccc2OCCCl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(S(=O)(=O)Nc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(S(=O)(=O)Nc2ccccc2)c(OC)cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(S(=O)(=O)Nc2ccc([N+](=O)[O-])cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1occc(=O)c1OC(=O)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1cc(CO)occ1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1occc(=O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1occc(=O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)N(C)C(O)C1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCN1CCNC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NCCN1CCO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CCc1ccccc1)NC(C)C(O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)SCn1c(=O)oc2cc(Cl)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c2cc(Cl)ccc2o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c2ccc(Cl)cc2o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c2ccccc2o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC=C(C(C)C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(C=O)C(C)(C)CC=C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CCC(C(C)C)C=C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC[C@H](C(C)C)C=C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@H](OC)[C@@H]1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2CC[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)[C@@H]1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NC(=O)C2CC=CCC12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C2CC=CCC2C(=O)N1SC(Cl)(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C2CC=CCC2C(=O)N1SC(Cl)(Cl)C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NC(=O)[C@@H]2CC=CC[C@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(/C=N\\NC(=O)c2ccncc2)c(C(=O)O)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(/C=N/NC(=O)c2ccncc2)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(N/N=C/c1ccccc1O)c1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)COc1ccccc1/C=N/NC(=O)c1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1ccc(OCCNC[C@H](O)c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC1CCCCC1c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC1(c2ccccc2)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc([C@@]2(O)CCCC[C@@H]2CN(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cc(C2CCCCC2)c(O)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C[C@@H](NS(=O)(=O)N(C)C)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCc1ccc(OCC2CO2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(OCC2CO2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1OCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(OCC2CO2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(Cc2cnc(N)nc2N)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(O)(c1ccc(OC(F)(F)F)cc1)c1cncnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C)c(Cc2cnc(N)nc2N)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H](C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cl)CS[C@H]12)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3ccccc3)[C@H]2SC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C1CCC(O)CC1)C1CCC(O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC1CCC(CC2CCC(N)CC2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CC(CC2CCC(N)C(C)C2)CCC1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C=NC1CCC(CC2CCC(N=C=O)CC2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1c2ccccc2c2cc([N+](=O)[O-])ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD) and cellular stress response (SR-HSE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1c2ccccc2c2cc(N)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)[nH]c1ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(=O)O)c1ccc2c(c1)[nH]c1ccc(Cl)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1nc2ccccc2nc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc2nccnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)Oc1cnc2ccccc2n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2nccnc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1=CCC=C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1O[C@H](O[C@@]2(CO)O[C@@H](O)[C@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC[C@H]1O[C@@](COC(C)=O)(O[C@H]2O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1O[C@H](O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCO[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]32)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]32)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H](OS(=O)(=O)O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN1C=CN(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCN1C=CN(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1C=CN(C)C1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN1C=CN(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(c1)CCCC2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCc2c(O)cccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C(I)=CC(=C(c2cc(I)c(O)c(I)c2)c2ccccc2C(=O)O)C=C1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(Br)C(=O)C(Br)=C/C1=C(\\c1ccccc1S(=O)(=O)O)c1cc(Br)c(O)c(Br)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccccc1C(=C1C=C(Br)C(=O)C(Br)=C1)c1cc(Br)c(O)c(Br)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(O)cc13 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(c1)[C@@]13CCCCC1[C@@H](C2)N(C)CC3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC1(COC(=O)CCC(=O)O)C(=O)N(c2ccccc2)N(c2ccccc2)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR) and cellular stress response (SR-ARE, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)CC(C)(C)c1ccc(O)c(-n2nc3ccccc3n2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)c1cc(-n2nc3ccccc3n2)c(O)c(C(C)(C)CC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(O)c(-n2nc3ccccc3n2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(-n2nc3ccc(Cl)cc3n2)c(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1c2occc2cc2ccc(=O)oc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1c2ccoc2cc2oc(=O)ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCOc1c2occc2cc2ccc(=O)oc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NNc1nc(-c2ccccc2)cs1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NNc1nc(-c2ccc(N)cc2)cs1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(-c2ccccc2)cs1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(-c2ccc([N+](=O)[O-])cc2)cs1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCn1sc(Cl)c(Cl)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCn1sccc1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-HSE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1sccc1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1sc(Cl)cc1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CN(CCN(C)C)c2ccccn2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCN(Cc1ccc(Cl)cc1)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCN(Cc1ccccc1)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c[nH]c(=S)[nH]c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(=O)[nH]c(=S)[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1cc[nH]c(=S)[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1cc(=O)[nH]c(=S)[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](C(C)=O)[C@@]4(C)CC[C@@H]32)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C2C(=O)c3ccccc3C2=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)C1c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)C1c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)C1c1ccc(Br)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[C@H]1CN2CCC1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[C@H]1CN2CCC1C[C@@H]2[C@@H](O)c1ccnc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[C@H]1CN2CCC1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](OC(=O)OCC)c1ccnc2ccc(OC)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](Cc1ccc(O)c(O)c1)[C@@H](C)Cc1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cc1ccc(O)c(O)c1)C(C)Cc1ccc(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H](Cc1cccc(O)c1)[C@H](CO)Cc1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCC)C(=O)Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)c1ccc(-c2cn3ccccc3n2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-Aromatase, NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(C2(c3ccc(N(C)C)cc3)OC(=O)c3cc(N(C)C)ccc32)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-ER-LBD) and cellular stress response (SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC(c2ccc(O)c(S(=O)(=O)O)c2)(c2ccc(O)c(S(=O)(=O)O)c2)c2c(Br)c(Br)c(Br)c(Br)c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC(c2ccc(O)cc2)(c2ccc(O)cc2)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C1=CC2C3C=CC(C3)C2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC1=C(Cl)C2(Cl)C3C(Cl)C=CC3C1(Cl)C2(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings. MODERATE-RISK: 7 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC2C3CC(C=C3C)C2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1cc(-c2ccccc2)nc2ccc(C)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(-c2ccccc2)nc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1c(O)c(-c2ccccc2)nc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(S(=O)(=O)Nc2nccs2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCC(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C=CC(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2ccc3cccc4ccc1c2c34 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc2ccc3cccc4ccc1c2c34 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc2ccc3cccc4ccc1c2c34 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=NN1CCCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCSC(=O)N1CCCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)N(NC(=O)c1ccc(Cl)cc1)C(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc(C(=O)NN(C(=O)c2cc(C)cc(C)c2)C(C)(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc(C(=O)NN(C(=O)c2cc(C)cc(C)c2)C(C)(C)C)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(c2ccccc2)C(=O)N(COC)C(=O)N(COC)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(c2ccccc2)C(=O)NC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(c2ccccc2)C(=O)NC(=O)N(C)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CC(=O)CC(C)(C)N1[O] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CC(=O)CC(C)(C)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)N1CCC(=O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1cc2c(cc1S(=O)(=O)O)[C@@]1(C)CCC[C@@](C)(C(=O)O)[C@@H]1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc2c(c1)CC[C@H]1[C@](C)(CN)CCC[C@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OCC(O)CO)c1ccccc1Nc1ccnc2c(C(F)(F)F)cccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(C(=O)OCCCOC(=O)c2ccc(N)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(OC(=O)c1ccccc1)C(C)(C)COC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(COC(=O)c1ccccc1)COC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COC(=O)OCN1C(=O)CN(CCN2CC(=O)N(COC(=O)OCC(C)C)C(=O)C2)CC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(-c2cc(C(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(-n2nc(C(F)F)cc2-c2ccc(S(C)=O)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2/C=N/OC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c([N+](=O)[O-])cccc3nc2-1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 5 rings containing 3 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[C@](C)(O)CC[C@@H]1[C@@]2(C)CCCC(C)(C)[C@@H]2CC[C@@]1(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC1(F)C(F)(F)C(F)(F)C2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C2(F)C1(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework. MODERATE-RISK: 18 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCC2CCCCC2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)OCC1CC2CC1C1CCC(COC(=O)C=C)C21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC1CC2CC1C1CCC(CO)C21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar polycyclic system with 3 rings. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1C[C@@H]2[C@@H]3CC[C@H](C3)[C@@H]2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CN(c2ccccc2)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCN(c2ccccc2)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(CO)CN(c2ccccc2)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2[nH]c(S(=O)Cc3ncc(C)c(OC)c3C)nc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H]1C[C@H]1c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)[C@]1(c2ccccc2)C[C@@H]1CN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc2c(ncn2COC(CO)CO)c(=O)[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)[nH]c(N)nc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc2c(ncn2COCCO)c(=O)[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2c(cc1OC)CN(C(=O)[C@H](C)N[C@@H](CCc1ccccc1)C(=O)O)[C@H](C(=O)O)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccc(S(N)(=O)=O)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCC(=O)N1CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(C)CC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCC(=O)N1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC12CC3CC(CC(C3)C1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar polycyclic system with 4 rings. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC12CC3CC(C)(C1)CC(N)(C3)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 4 rings. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(N)C12CC3CC(CC(C3)C1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 4 rings. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC[C@H]2C[C@@H]1C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC[C@@H]2C[C@H]1C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CCC2CC1C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCN1CC[C@]2(C)c3cc(O)ccc3C[C@H]1[C@H]2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCN1CC[C@@]2(C)c3cc(O)ccc3C[C@@H]1[C@@H]2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)C1C(=O)c2ccccc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(=O)C1C(=O)c2ccccc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)C1(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c2ccccc2n1C1CCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c2cc(Cl)ccc2n1C1CCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)N1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(=O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)N(c1ccccc1)C1CCN(CCc2cccs2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)N(c1ccccc1)C1CCN(C(C)Cc2cccs2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(S(=O)(=O)Nc2ccc(Cl)nn2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O[C@@H]1CC(=O)O[C@H](C)CC=CC=C[C@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@H]1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings. MODERATE-RISK: reactive aldehyde. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)C=CC=CC[C@@H](C)OC(=O)C[C@H]1OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings. MODERATE-RISK: reactive aldehyde. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)C=CC=CC[C@@H](C)OC(=O)C[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings. MODERATE-RISK: reactive aldehyde. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(Cc1c(F)cccc1Cl)c1c([N+](=O)[O-])cc(C(F)(F)F)cc1[N+](=O)[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase, NR-ER) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(Cc1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(Cc1cccc(S(=O)(=O)O)c1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCO[C@@H]1[C@H]2OC(C)(C)O[C@H]2O[C@@H]1C(O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@@H](O)[C@H]1O[C@@H]2O[C@@H](C(Cl)(Cl)Cl)O[C@@H]2[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@@H](O)[C@H]1O[C@@H]2O[C@H](C(Cl)(Cl)Cl)O[C@@H]2[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1cc(S(=O)(=O)O)cc2cc(S(=O)(=O)O)c(N=Nc3ccccc3)c(O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1/N=N/c1c(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(NC(C)=O)c2c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)c(S(=O)(=O)O)cc1N=Nc1cc(S(=O)(=O)O)c2ccccc2c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CCC1=C(C)[C@H](OC(=O)[C@H]2[C@H](C=C(C)C)C2(C)C)CC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCC1=C(C)[C@@H](OC(=O)[C@@H]2[C@@H](C=C(C)C)C2(C)C)CC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCC1=C(C)C(OC(=O)C2C(C=C(C)C)C2(C)C)CC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[C@H](C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1)c1ccc(OC(F)F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[C@H](C(=O)O[C@H](C#N)c1cccc(Oc2ccccc2)c1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(c1)c(CC(=O)OC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C)c(C)n2C(=O)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(CNCc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ON(Cc1ccccc1)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(Cc1ccccc1)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 6 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5ccccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 6 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)Oc1c(OC)cc(C(=O)O[C@@H]2C[C@@H]3CN4CCc5c([nH]c6cc(OC)ccc56)[C@H]4C[C@@H]3[C@H](C(=O)OC)[C@H]2OC)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 6 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1-c1c2cc(I)c(=O)c(I)c-2oc2c(I)c(O)c(I)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2cc(I)c(=O)c(I)c-2oc2c(I)c(O)c(I)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 8 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1-c1c2cc(Br)c(=O)c(Br)c-2oc2c(Br)c(O)c(Br)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)N/N=C/c1c[n+]([O-])c2ccccc2[n+]1[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [O-][n+]1cc[n+]([O-])c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(C(=O)NCCO)[n+]([O-])c2ccccc2[n+]1[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2cc3c(cc2CCN1C)OCO3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(c1OC)C(=O)O[C@H]2[C@@H]1c2cc3c(cc2CCN1C)OCO3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2c(c1)CCCN2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc2c(c1)C(C)CC(C)(C)N2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC1CCc2cc(CO)c([N+](=O)[O-])cc2N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CN1CCCCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCN1CCCCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1=COCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC1CCC=CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1NC(=N)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cl[C@H]1OCCO[C@@H]1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1COCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC1OCCOC1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1-n1c(CF)nc2ccc(N)cc2c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AhR, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc2ccccc2c(=O)n1-c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1-n1c(C)nc2ccccc2c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@H]1O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)C24OO3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1[C@H](OC(=O)CCC(=O)O)O[C@@H]2O[C@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1C24OO3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[C@H]1O[C@@H]2OC3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(/C=C/c1ccc([N+](=O)[O-])cc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C=CC(=O)c2ccc(OC)cc2OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1cnc2c(=O)nc(N)[nH]c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(=O)c2ncn(CCC(CO)CO)c2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[C@H](N)C(=O)OCC(CO)OCn1cnc2c(=O)nc(N)[nH]c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(c1ccc(O)cc1)(c1ccc(O)cc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(C(c2ccccc2)c2ccc(N(C)C)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1C(c1ccc(O)cc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CCNC[C@H](O)c2ccc(O)cc2)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](NCCc1ccc(O)cc1)[C@H](O)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1ccc2c(c1)N(CCCN1CCC(O)CC1)c1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(O)c1ccc(O)cc1)N1CCC(Cc2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\\c1ccc(S(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\\c1ccc(S(C)(=O)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCCCCNC1c2ccccc2CCc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)C1c2ccccc2CCc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CC1c2ccccc2CCc2ccccc21)CN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)N(C)c1nnc(C(C)(C)C)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1nnc(S(N)(=O)=O)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Sc1nnc(S)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[C@]1(C)C[C@@H](OC(=O)CSC(C)(C)CNC(=O)[C@H](N)C(C)C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[C@]1(C)C[C@@H](OC(=O)CSCCN(CC)CC)[C@]2(C)C(C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC1(C)CC(OC(=O)CO)C2(C)C(C)CCC3(CCC(=O)C32)C(C)C1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-AhR) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCNc1ccc(CNC=O)c2sc3ccc(OC)cc3c(=O)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1ccc2sc3ccccc3c(=O)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(c1ccc([N+](=O)[O-])cc1)c1c(O)c2ccccc2oc1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(CC2=NCCN2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1COC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1COC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc[nH]n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1nc[nH]n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)Oc1nc(Cl)n(C(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1([O-])[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC1CC2C=CC1C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C1C(C(=O)O)C2(Cl)C(Cl)=C(Cl)C1(Cl)C2(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC1=C(Cl)C2(Cl)C(CBr)CC1(Cl)C2(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework. MODERATE-RISK: 7 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOC(=O)C(=O)Nc1cccc(-c2nnn[nH]2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(-c2nnn[nH]2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C(=O)Nc1cccc(-c2nnn[nH]2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(CCC=C2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cc2cc(OC)c(OC)cc2c(Cc2ccccc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(Oc1ccc(Cl)cc1Cl)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(Oc1ccc(Cl)cc1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(Oc1ccc(Cl)cc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(=O)nc(C(C)C)[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1nc(=O)c(F)c[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(=O)nc(N)[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c2ccccc2nc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER) and cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc2cc3ccc(N)cc3nc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD, NR-AhR, NR-Aromatase, NR-ER) and cellular stress response (SR-ARE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc2nc3cc(N)ccc3c(N)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-AhR, NR-Aromatase) and cellular stress response (SR-HSE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 9 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-ATAD5, SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 9 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ATAD5, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 9 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)O[C@@H]1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 8 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 8 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD) and cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]5(C)[C@@H](C7=CC(=O)OC7)CC[C@]65O)C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 8 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-Aromatase, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=NN1CCCCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NCCN1CCCCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCCNCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@@]1(NC(=O)Cc2cccs2)C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3cccs3)[C@H]2SC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCOc1ccc(C(=O)CCN2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCC(C2CCCCC2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC1CCC(C2CCCCC2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cnn(-c2ccccc2)c(=O)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNc1cnn(-c2cccc(C(F)(F)F)c2)c(=O)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)COc1cc(-n2ncc(C(F)(F)F)c(C)c2=O)c(F)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule BrC1CCC(Br)C(Br)CCC(Br)C(Br)CCC1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic monocyclic system. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCCCCCCCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC1CCCCCCCCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1NC(=O)C1CCCCN1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(-c2noc(CC(=O)O)c2-c2ccc(OC)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1([O-])[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C1=CC2=CC[C@@H]3[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@]1(C)CCC[C@@]2(C)[C@H]1CC=C1C=C(C(C)C)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 7 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C2CC[C@]3(C)[C@H](C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@]43C)[C@@]2(C)CC[C@@H]1O[C@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 7 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc(C[n+]2csc(CCOP(=O)(O)OP(=O)(O)O)c2C)c(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc(C[n+]2csc(CCOP(=O)(O)O)c2C)c(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccccc1C(=O)OCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AhR, NR-ER) and cellular stress response (SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OCCc1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1/C(=C2\\Nc3ccc(S(=O)(=O)O)cc3C2=O)Nc2ccc(S(=O)(=O)O)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1/C(=C2\\Nc3ccccc3C2=O)Nc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](N[C@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1nc(NC2CC2)nc(NC(C)(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C#N)Nc1nc(Cl)nc(NC2CC2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(N)nc(NC2CC2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOc1ccccc1C(=O)CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC1(c2ccccc2Cl)CCCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@@]1(c2ccccc2Cl)CCCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@]1(c2ccccc2Cl)CCCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(-c2ccc(N=Nc3c(S(=O)(=O)O)cc4cc(S(=O)(=O)O)cc(N)c4c3O)c(C)c2)ccc1N=Nc1c(S(=O)(=O)O)cc2cc(S(=O)(=O)O)cc(N)c2c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings containing 6 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(/N=N/c2ccc(-c3ccc(/N=N/c4cc(S(=O)(=O)O)c5ccccc5c4N)cc3)cc2)cc(S(=O)(=O)O)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings containing 6 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(-c2ccc(/N=N/c3ccc4c(S(=O)(=O)O)cc(S(=O)(=O)O)c(N)c4c3O)c(C)c2)ccc1/N=N/c1ccc2c(S(=O)(=O)O)cc(S(=O)(=O)O)c(N)c2c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings containing 6 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P1(NCCCl)OCCCN1CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P1(N(CCCl)CCCl)NC(OO)CCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P1(N(CCCl)CCCl)NCCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](C)[C@@H](C(=O)O)n1sc2ccccc2c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]sc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]sc2cc(Cl)ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)COc1nn(Cc2ccccc2)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C1OC1c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(C2CO2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C1OC1(C)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cnc(C2=NC(C)(C(C)C)C(=O)N2)c(C(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCc1cnc(C2=NC(C)(C(C)C)C(=O)N2)c(C(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C1(C)N=C(c2ncccc2C(=O)O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC1COC(Cn2cncn2)(c2ccc(Cl)cc2Cl)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(C2(Cn3cncn3)OCCO2)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1COC(Cn2cncn2)(c2ccc(Cl)cc2Cl)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC(=O)O[C@@H]1CC(C)=C(/C=C/C(C)=C/C=C/C(C)=C/C=C\\C=C(C)\\C=C\\C=C(C)\\C=C\\C2=C(C)C[C@@H](OC(=O)CCCCCCCCCCCCCCC)CC2(C)C)C(C)(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C[C@@H](O)CC2(C)C)C(C)(C)C[C@H](O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C\\C=C(C)\\C=C\\C=C(C)\\C=C\\C2=C(C)CCCC2(C)C)C(C)(C)CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)C1c1ccc2cc(S(=O)(=O)O)cc(S(=O)(=O)O)c2n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 3 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)C1c1ccc2ccccc2n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)C1c1nc2ccccc2c(Br)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc2[nH]cc(CCCCN3CC=C(c4ccccc4)CC3)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc2[nH]cc(CCCCN3CC=C(c4ccccc4)CC3)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 8 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 8 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C1\\C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C1/C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C2=CC(=O)C(=NNC(N)=O)C=C2CC1S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CC(O)C2=C/C(=N/NC(N)=O)C(=O)C=C21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(O)CC[C@H]2[C@@H]3[C@H](C)CC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C(=O)Cc1ccccc1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(C(=O)O)N2C(=O)[C@@H](N)[C@H]2SC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](N)[C@H]2SC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1c2c(cc3c1OCO3)CCN(C)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCc2cc3c(cc2C1O)OCO3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[Si]1(C)O[Si](C)(C=C)O[Si](C)(C=C)O[Si](C)(C=C)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NC(=O)c2cccc3cccc1c23 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CN1C(=O)c2cccc3cccc(c23)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(=O)n([C@@H]2CS[C@H](CO)O2)cc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccn([C@H]2CS[C@@H](CO)O2)c(=O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ncnc(Nc2ccccc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ncnc(Nc2ccc(Cl)cc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1OC(=O)CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(Nc2ccc(O)c3c2C(=O)c2ccccc2C3=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2c(O)ccc(Nc3ccc(CCO)cc3)c2C(=O)c2c([N+](=O)[O-])ccc(O)c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)OC[C@@H]2O[C@@]3(C(=O)O)OC(C)(C)O[C@H]3[C@@H]2O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC12CCC(CC1=O)C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ncc(F)c2nc(S(=O)(=O)Nc3c(F)cccc3F)nn12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1nc(F)cc2nc(S(=O)(=O)Nc3c(Cl)cccc3Cl)nn12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1[C@@H]2Cc3ccc(O)cc3[C@@]1(C)CCN2CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1[C@H]2Cc3ccc(O)cc3[C@]1(C)CCN2CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 5 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCCN=C1/C=C/c1cccs1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccsc1/C=C/C1=NCCCN1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)[N-]c1c[n+](N2CCOCC2)no1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c[n+](N2CCOCC2)no1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(COCC(C)OC(=O)c1ccccc1)OC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OCCOCCOC(=O)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CN2CCC1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar polycyclic system with 3 rings. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC1CN2CCC1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(O)C(=O)CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(O)C(=O)C(C)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase, NR-ER) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccccc1CN1CCc2sccc2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CC(=O)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(=O)CC(=O)c2ccc(C(C)(C)C)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1Nc2ccccc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1Nc2ccc([N+](=O)[O-])cc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C1C=CC(=C(c2ccc(N)cc2)c2ccc(N)cc2)C=C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C(=C2C=CC(=N)C=C2)c2ccc(N)cc2)ccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C1CCCCC1)S(=O)(=O)c1ccccc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(S(=O)(=O)NC2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(NC(CCc1ccccc1)C(=O)O)C(=O)N1C(=O)N(C)CC1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n1cncn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(O)C(Oc1ccc(Cl)cc1)n1cncn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1onc(-c2ccccc2)c1C(=O)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@@H]([C@H]5O[C@@H]45)[C@@H]3[C@@]1(Cl)C2(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@H]4C[C@H]([C@@H]5O[C@H]45)[C@@H]3[C@@]1(Cl)C2(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C(O)=C1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-Aromatase, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 6 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 6 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(=O)c2ccccc2o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1coc2ccccc2c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@@H]1[C@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD, NR-Aromatase, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@]1(C)[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC(c1ccc(F)cc1)(c1cncnc1)c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC(c1ccc(Cl)cc1)(c1cncnc1)c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3\\C[C@@H](O)CC[C@@H]3C)CCC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings. Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1cc[nH]c1=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)n1ccn(C)c1=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2c(cc1N)oc1ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)oc1ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(N(C)C)c3ccccc32)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(OC)SCn1nnc2ccccc2c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)SCn1nnc2ccccc2c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(OCCOCC[N+](C)(C)Cc2ccccc2)ccc1C(C)(C)CC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2nc(-c3ccc(N)cc3)sc2c1S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOc1ccc(-c2nc3cc(Cl)ccc3s2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C2CCC1CC(OC(c1ccccc1)c1ccc(Cl)cc1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)OC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOc1nn(C(=O)NS(=O)(=O)c2ccccc2C(=O)OC)c(=O)n1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1nn(C(=O)NS(=O)(=O)c2ccccc2OC(F)(F)F)c(=O)n1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(=O)[nH]cc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc[nH]c(=O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)N(C)C(=O)c1cc2ccccc2c(-c2ccccc2Cl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1cc(-c2nccc3cc(OC)c(OC)cc23)cc(OCC)c1OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccc(OCCN2C[C@H](O)[C@@H](O)[C@H](O)[C@H]2CO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(OCCN2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2occc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=Cc1cc2ccccc2o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: reactive aldehyde. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 6 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](OC(C)=O)[C@@H](N6CCCCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(=O)CC)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(C(=O)c1ccc(Br)cc1)c1ccc(Br)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(C(=O)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cc2c3c(cccc3c1)CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc2c3c(cccc13)CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@H](Cn1c2nc(=O)[nH]c(=O)c-2nc2cc(C)c(C)cc21)OC(=O)CCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(Cl)c(NC2=NCCN2)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCN(C1=NCCN1)c1c(Cl)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc(-c2ccncc2)c[nH]c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=NN(c2cc(Cl)c(S(=O)(=O)O)cc2Cl)C(=O)C1/N=N/c1ccc(S(=O)(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=NN(c2cc(S(=O)(=O)O)ccc2Cl)C(=O)C1/N=N/c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nnc2n1-c1sc(Br)cc1C(c1ccccc1Cl)=NC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2nc(Cl)nc(N)c2cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ncnc2cc(OC)c(OC)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(Cl)cc1C1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOCCOC(=O)C1(c2ccccc2)CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c2c(nc3ccccc13)CCCC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c2c(nc3ccccc13)CCCC2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(/C(=C\\CN2CCCC2)c2ccccn2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(/C(=C\\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@@H]1CC2C3CCc4cc(OC(=O)c5ccccc5)ccc4C3CCC2(C)[C@H]1OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C(O)C(C)(C)C1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C1CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)-c1cccc3cccc-2c13 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc2c3c(cccc13)-c1ccccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCC)CCc1cccc2c1CC(=O)N2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1Cc2cc(Cl)ccc2N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCC[C@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2cc3c(ccc4ccccc43)cc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c2ccccc2c(C)c2c1ccc1ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)Oc1ncn(-c2ccccc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1nc(C(Cl)(Cl)Cl)n(-c2ccc(Cl)cc2Cl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCCC1CCSS1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)CCCCC1CCSS1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CC1(C)OCC(C)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1COCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#C/C(=C1/SC[C@@H](c2ccc(Cl)cc2Cl)S1)n1ccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#C/C(=C1\\SCC(c2ccccc2Cl)S1)n1ccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@H](C(=O)O)[C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@]3(C=C[C@@H](O)[C@]4(CC[C@@](C)([C@H]5CC[C@](O)(CC)[C@H](C)O5)O4)O3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@@H]1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1cc2c(cc1C(F)(F)F)NC(Cc1ccccc1)NS2(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1cc2c(cc1Cl)NC(Cc1ccccc1)NS2(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12C(=O)OC(=O)[C@H]1[C@H]1C=C[C@@H]2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC(=O)C2C3C=CC(C3)C12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2c(O)c(S(=O)(=O)[O-])cc3cc(S(=O)(=O)O)ccc23)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNc1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2ccc(N(CC)CC)cc2)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN/C(=N\\c1ccc(C2=NNC(=O)CC2C)cc1)NC#N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1CC(=O)NN=C1c1ccc(NN=C(C#N)C#N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCNc1c(C(=O)OCC)c(C)nc2c1cnn2CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCSc1ccccc1NC(=O)/C=C/c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(Nc1ccccc1)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1NC(=N)Nc1ccccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN[C@@H]1C[C@H](N)[C@@H](OC2OC(CN)=CCC2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](OC3OC(CN)=CCC3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CN(CCN(C)C)c2ncccn2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c1ncccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NC(=O)N1CC(=O)N(c2cc(Cl)cc(Cl)c2)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(c1cc2ccccc2s1)N(O)C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1cc2ccccc2s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1CCC2CC1C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1CC[C@H]2C[C@@H]1C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)Oc1ccccc1O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(OCCO)c(OCCO)c4)oc4cc(OCCO)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1OC(C)OC(C)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1OCOCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1ccc(C2(c3ccc(OC(C)=O)cc3)C(=O)Nc3ccccc32)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1Nc2ccccc2C1(c1ccc(O)cc1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOc1ccc2c(c1)C(=O)c1cc(OCCN(CC)CC)ccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2-c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(N)nc(-c2ccccc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C(=S)N2CCOCC2)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C(=S)N2CCOCC2)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CCN(C)CCCC(C#N)(c2cc(OC)c(OC)c(OC)c2)C(C)C)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(CCNCCCCCCNCCc2ccccc2)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(C(O)CNCCCCCCNCC(O)c2ccc(O)c(O)c2)cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCCOc1ccnc(CS(=O)c2nc3ccccc3[nH]2)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nn1cnnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nnc(N)[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2[nH]c(-c3cscn3)nc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)OC(=O)Nc1ccc2[nH]c(-c3cscn3)nc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC[C@@H]1C=C(C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@H]1C=C(C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(S(=O)(=O)Nc2cc(C)on2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1cnc2ncnc(N)c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1nc(N)nc2nc[nH]c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1cc(=O)c2c(OCC(COc3cccc4oc(C(=O)OCC)cc(=O)c34)OC(=O)[C@@H](N)CCCCN)cccc2o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 4 rings containing 4 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 4 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(C2(c3ccc(O)cc3)CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(Oc1ccc(C2(c3ccc(OC(C)(CC)C(=O)O)cc3)CCCCC2)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)[C@@H]1C[C@]2(NC(=O)NC2=O)c2cc(F)ccc2O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NC(=O)[C@@]2(CCOc3ccc(F)cc32)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cn1cnnn1)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nncs3)CS[C@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cnnn4)[C@H]3SC2)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(Nc2ccc3ccccc3c2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1cc(O)c2ccc(Nc3ccccc3)cc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)C(CC(C)C)NC=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)S[C@@H]2[C@H](/N=C/N3CCCCCC3)C(=O)N2[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](N=CN3CCCCCC3)[C@H]2SC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1[C@@H]2CC[C@H]1CC(OC(=O)c1c[nH]c3ccccc13)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(=O)Nc1cccc(C2CN3CCSC3=N2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc([C@H]2CN3CCSC3=N2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](CNS(N)(=O)=O)C3)[C@H](C)[C@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O[C@@H](C(=O)O)[C@@H](OC(=O)c1ccccc1)C(=O)O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(COC(=O)c1ccccc1)OC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)cc(OCC2CNC(=O)O2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1OCC1CNC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 6 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)Sc1ccccc1N2C[C@@H]1CN2CCC1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 6 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S1OC[C@@H]2[C@H](CO1)[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S1OCC2C(CO1)C1(Cl)C(Cl)=C(Cl)C2(Cl)C1(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(OC)nc(O[C@H](C(=O)O)C(OC)(c2ccccc2)c2ccccc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CC2OC2CC1C1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar polycyclic system with 3 rings. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1OC1C1CCC2(C)OC2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar polycyclic system with 3 rings. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ATAD5, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc([C@@H]2c3cc4c(cc3[C@@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ATAD5, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(=O)OCOC(=O)C1N2C(=O)CC2S(=O)(=O)C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCC(=O)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CC(C)C(=O)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)N(c1ccccc1)C1CCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)N1CCC(Nc2ccc(Cl)cc2N)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(N)(=O)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(c1ccc(OCC2CO2)cc1)c1ccc(OCC2CO2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cc(OCC2CO2)ccc1Cc1ccc(OCC2CO2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(OCCOc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(OCCOc2cccc(C)c2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC1=C(Cl)C2(Cl)C3C(Cl)C(Cl)CC3C1(Cl)C2(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings. MODERATE-RISK: 8 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC1=C(Cl)[C@@]2(Cl)[C@@H]3[C@@H](Cl)C(Cl)C[C@@H]3C1(Cl)C2(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings. MODERATE-RISK: 8 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C2[C@@H]([C@H](C)CC[C@H]2/C=C(\\C)C(=O)O)[C@H](O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C2[C@H](/C=C(\\C)C(=O)O)CC[C@@H](C)[C@H]2CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CCC(Cc2ccc(Cl)cc2)C1(O)Cn1cncn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C1CCC(Cc2ccc(Cl)cc2)C1(O)Cn1cncn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)OC(C)(C)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)OC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)c1c(I)c(NC(=O)CCCCC(=O)Nc2c(I)c(C(=O)O)c(I)c(C(=O)NC)c2I)c(I)c(C(=O)O)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(F)c(F)c(COC(=O)C2C(/C=C(\\Cl)C(F)(F)F)C2(C)C)c(F)c1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 8 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCc1c(F)c(F)cc(F)c1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(O)OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@H](C(=O)[C@@H](O)[C@@H](C)O)C1Cc2cc3cc(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@@H](O)[C@@H](C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1O[C@H]1C[C@@H](O[C@H]2C[C@@H](O[C@H]3C[C@](C)(O)[C@H](O)[C@@H](C)O3)[C@H](O)[C@@H](C)O2)[C@H](O)[C@@H](C)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 8 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@@H]1[C@H](O)C[C@@H](O[C@@H]2C[C@H](Oc3cc4cc5c(c(O)c4c(O)c3C)C(=O)[C@@H](O[C@H]3C[C@@H](O[C@H]4C[C@@H](O[C@H]6C[C@](C)(O)[C@@H](OC(C)=O)[C@H](C)O6)[C@H](O)[C@@H](C)O4)[C@H](O)[C@@H](C)O3)[C@H]([C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)C5)O[C@H](C)[C@@H]2OC(=O)O)O[C@@H]1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 8 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(=C(\\CCOC(=O)C(C)C)SS/C(CCOC(=O)C(C)C)=C(/C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=C(CCO)SSC(CCO)=C(C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)c1cc2[o+]c3cc(N(CC)CC)c(C)cc3c(-c3ccc(S(=O)(=O)O)cc3S(=O)(=O)[O-])c2cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)c1ccc2c(-c3ccccc3C(=O)O)c3ccc(N(CC)CC)cc3[o+]c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Br)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase, NR-ER) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(CCC(=O)N2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCN1CCN(CCO)CC1)N1c2ccccc2Sc2ccc(C(F)(F)F)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)n1c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c2ccccc2c(=O)n1CCCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2[nH]c(=O)[nH]c(=O)c2cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(Oc1ccc([N+](=O)[O-])cc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=S)(Oc1cc(Cl)c(Br)cc1Cl)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [OH][Sn]([c]1ccccc1)([c]1ccccc1)[c]1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-ER-LBD) and cellular stress response (SR-ATAD5, SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [F][Sn]([c]1ccccc1)([c]1ccccc1)[c]1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(CN2CCNCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CN2CCNCC2)c(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCC[C@H]1c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCC[C@@H]1c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1COP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@H]1CCc2cc(OC)c(OC)c(OC)c2-c2ccc(OC)c(=O)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ATAD5, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1NC(=O)c1cc2ccccc2cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1cccc([N+](=O)[O-])c1)c1cc2ccccc2cc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO[Si](CCC1CCC2OC2C1)(OCC)OCC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCC2OC2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2OC(=O)CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2OC(=O)CCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 5 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[Si](Cl)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cl[Si](Cl)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CC/C=C1\\c2ccccc2COc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)/C=C/c2ccc(O)c(OC)c2)[C@@H]1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 6 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)C=Cc2cc(OC)c(OC)c(OC)c2)[C@@H]1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 6 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC1=C(Cl)[C@]2(Cl)[C@H]3[C@H]([C@H]4C=C[C@H]3C4)[C@@]1(Cl)C2(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@H]4C=CC(C4)[C@@H]3C1(Cl)C2(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1cc2ccccc2c(OCCN(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2cnccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(Cl)Cc1cc(-n2nc(C)n(C(F)F)c2=O)c(F)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nn(-c2cc(NS(C)(=O)=O)c(Cl)cc2Cl)c(=O)n1C(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CN(C[C@@H](OP(=O)(O)O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(c2ccccc2)CCC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(c2ccc(N)cc2)CCC(=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)[C@@H](C)Oc1ccc(Oc2nc3ccc(Cl)cc3o2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(C)Oc1ccc(Oc2nc3ccc(Cl)cc3o2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@@H](O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 5 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@@H](OC(=O)CCC(=O)O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2c(cc1OC)[C@@H](c1ccccc1)CN(C)CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C\\CC1=C(C)CCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCC1=CCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2c(cc1OC)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 7 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 7 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc([N+](=O)[O-])cn1-c1ccc([N+](=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)c1ccccc1-n1ccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)c1ccc(OCC(=O)N2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(=N\\O)c1ccc(OCC(=O)N2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nnc(-c2ccc([N+](=O)[O-])o2)o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(-c2nnc(O)o2)o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AhR) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1csc(-c2ccc(Cl)cc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOc1cccc(S(=O)(=O)Nc2ncccn2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc([C@@H]2c3cc4c(cc3C(O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)C3COC(=O)[C@@H]32)OCO4)cc(OC)c1OP(=O)(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 7 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc([C@@H]2c3cc4c(cc3C(O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)C3COC(=O)[C@@H]32)OCO4)cc(OC)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 7 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=C[C@@H]1[C@@H](C(=O)OCc2coc(Cc3ccccc3)c2)C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=CC1C(C(=O)OCc2coc(Cc3ccccc3)c2)C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc(N)nc(N)c1-c1ccc(Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(c1c(O)c2ccccc2oc1=O)c1c(O)c2ccccc2oc1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 4 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 4 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1nn(-c2c(Cl)cc(C(F)(F)F)cc2Cl)c(N)c1S(=O)C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 8 halogen atom(s) (potential bioaccumulation), aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(N)n(-c2ccccc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(C2=Nc3cc(F)ccc3Cc3ccccc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(C2=Nc3ccccc3Cc3ccccc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC1=C(Cl)C(Cl)(Cl)C(Cl)=C1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(N=[N+]([O-])c2ccc(OC)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [O-][N+](=Nc1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(C(O[C@H]2CCCN(CCc3ccc4c(c3)OCO4)C2)c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(C(O[C@@H]2CCCN(CCc3ccc4c(c3)OCO4)C2)c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(C)c1ccc(CC(C)CN2C[C@@H](C)O[C@@H](C)C2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 1 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cc1ccc(C(C)(C)C)cc1)CN1C[C@@H](C)O[C@@H](C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCN(S(C)(=O)=O)C3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)S[C@@H]2[C@H](NC(=O)[C@@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC1CCCCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCCCC1NC(=O)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NCC(O)COc1ccc(NC(=O)NC2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNCCC=C1c2ccccc2CCc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCC=C1c2ccccc2CCc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCC(NC2CCCCC2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C1CCCCC1)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2c(n1)Oc1ccc(C(C)C(=O)OCC(=O)N(C)C)cc1C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(=O)O)c1ccc2c(c1)Cc1cccnc1O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(F)cc2c(=O)c(C(=O)O)cn3c2c1CCC3C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCc2cc(F)cc3c(=O)c(C(=O)O)cn1c23 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1COC2(c3ccccc3Cl)c3cc(Cl)ccc3NC(=O)CN12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CN2CCOC2(c2ccccc2Cl)c2cc(Cl)ccc2N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NN=Cc1ccc([N+](=O)[O-])o1)c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 6 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CO)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)[C@H]1CCC(=O)N1)C(=O)N[C@H](CCCNC(=N)N)C(=O)N1CCC[C@@H]1C(=O)NCC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 6 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(CC(=O)O)n(C)c1C(=O)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2c(O)cccc2Cc2cccc(O)c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2Cc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC1(c2ccccc2)CCN(CCc2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)C(O)/C(=C\\c1ccc(Cl)cc1Cl)n1cncn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cl/C(=C\\n1cncn1)c1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC(O)COc1ccccc1-n1cccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(CC(=O)O)c(C)n1-c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C1(C(=O)Nc2ccc(Cl)cc2Cl)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc(Cl)c(Cl)c1)C1CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCCC(OC(=O)C(c2ccccc2)c2ccccc2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C(C(=C/C)/c1ccc(O)cc1)\\c1ccc(O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C(C(=C/C)/c1ccc(OC(C)=O)cc1)\\c1ccc(OC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cc(S(=O)(=O)O)c2cc(C(C)C)cccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(C)C)cc2c(C)ccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic bicyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)Cc1cccc(-c2cc(CCCCCCc3ccc(O[C@H]4O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H]4OC(C)=O)c(-c4cccc(CC(=O)OCC)c4)c3)ccc2O[C@H]2O[C@H](COC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H]2OC(C)=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings containing 4 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1cccc(-c2cc(CCCCCCc3ccc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]4O)c(-c4cccc(CC(=O)O)c4)c3)ccc2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 6 rings containing 4 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(N[C@H]1N=C(c2ccccc2F)c2cccc3c2N(CC3)C1=O)c1cc2ccccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 6 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(N[C@@H]1N=C(c2ccccc2F)c2cccc3c2N(CC3)C1=O)c1cc2ccccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 6 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ATAD5, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule S=C(Nc1ccccc1)Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(NC(=S)Nc2ccc(OCC)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CSCCS1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(O)CSC(C)(O)CS1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(C)(COC(N)=O)COC(=O)NC1CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C[C@@H]1C(=O)N/C(=C\\CCCCSC[C@H](N)C(=O)O)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(=N\\Cc1ccccc1)c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccccc1C=NCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)OC[C@@H]1[C@H](NC(=O)/C(=N\\OCC(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1[C@H](NC(=O)C(=NOC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 5 rings containing 5 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD, NR-AhR, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc2c1cc1ccc3cccc4ccc2c1c34 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic polycyclic system with 5 rings containing 5 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-AhR, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)CC(C)(c2ccccc2)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)CC(c2ccccc2)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1onc(-c2c(Cl)cccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc2nc3ccc(N(C)C)cc3[s+]c2cc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N(c1onc(C)c1C)S(=O)(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C(=C/c1ccccc1)\\CN1CCN(C(c2ccccc2)c2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC[C@@]23CC1C(C)(C)[C@@H]2CC[C@H]3C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C1=C(C)[C@@H]2C[C@@]3(C1)[C@H](C)CC[C@H]3C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)c1ccc(C(=O)C2C(=O)CCCC2=O)c(Cl)c1COCC(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)c1ccc(C(=O)C2C(=O)CCCC2=O)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)nc(Nc2ccccc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC#Cc1cc(C)nc(Nc2ccccc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ncn2c1CN(C)C(=O)c1c(I)cccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOC(=O)C1(c2ccccc2)CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNC(=O)NCCCOc1cccc(CN2CCCCC2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(Cc2c[nH]cn2)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C(C)c2c[nH]cn2)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(=N)N)[C@@H](O)[C@@H]3NC(=N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 3 rings. MODERATE-RISK: reactive aldehyde. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(=N)N)[C@@H](O)[C@@H]3NC(=N)N)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 3 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]2O)[C@@H](N)C[C@@H]1NC(=N)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@@H]1[C@H](OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@@H]1[C@H](OC(=O)NC(=O)CCl)CC[C@]2(CO2)[C@H]1[C@]1(C)O[C@@H]1CC=C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCCCC1CCN1c2ccccc2Sc2ccc(S(C)=O)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S1(=O)CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S1(=O)CC(Cl)(Cl)C(Cl)(Cl)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](CC=C(C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@H](NC(C)=O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)C=CC=C3CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 7 rings. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](CC=C(C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)C=CC=C3CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 7 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)NC1CCSC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CSCC(=O)NC1CCSC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic monocyclic system. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc([C@@H]2Sc3ccccc3NC(=O)[C@@H]2O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(Cc1cccc(S(=O)(=O)O)c1)c1ccc(C(=C2C=CC(=[N+](CC)Cc3cccc(S(=O)(=O)[O-])c3)C=C2)c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(Cc1cccc(S(=O)(=O)O)c1)c1ccc(C(=C2C=CC(=[N+](CC)Cc3cccc(S(=O)(=O)O)c3)C=C2)c2ccc(O)cc2S(=O)(=O)[O-])cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1cc2c(cc1Cl)N=CNS2(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCC/C=C\\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(Cl)c2)[C@H](O)C[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCC/C=C\\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Oc1ccccc1)Oc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1OC(=O)Oc1ccccc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC(C)(C)Nc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc2c(c1)C(C)=CC(C)(C)N2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCC(C(C)C)C(OC(=O)c2ccccc2N)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CC(OC(=O)c2ccccc2O)CC(C)(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1C[C@H](O)c2ccsc2S1(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1COc2ccccc2N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1COc2ccccc2N1C(=O)C(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-ATAD5, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccccc1C(=O)Oc1ccc2ccccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(Nc1ccc(C(F)(F)F)cc1Cl)C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)[C@@H](Nc1ccc(C(F)(F)F)cc1Cl)C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1C(=O)NC(c2ccccc2)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@]1(c2ccccc2)NC(=O)N(C)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(c1OC)CN1CCc3cc4c(cc3C1C2)OCO4 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 5 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc2ccccn2c(=O)c1CCN1CCC(C(=O)c2ccc(F)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(=O)n(-c2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)O[C@H]2CC(=O)OC[C@]23[C@H]2CC[C@@]4(C)[C@H](c5ccoc5)OC(=O)[C@H]5O[C@]54[C@]2(C)C(=O)C[C@@H]13 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 7 rings containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CC(=O)NC1=N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1CC[C@@H]2[C@](C)(CO)[C@H](O)CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]cnc2nc[nH]c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CN(N=Cc2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1c(N)nc2c3cccnc3ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1cn2nc(OP(=S)(OCC)OCC)cc2nc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(CCCc2ccccn2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule S=C1NC=NC2N=CNC12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N[C@@H]1C(O[C@H]2O[C@H](C(=O)O)C(O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1C(C(=O)O)O[C@@H](O[C@H]2[C@H](O)[C@@H](CO)OC(O)[C@@H]2NC(C)=O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule S=c1[nH]c2ccccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCNc1nc(NCC=C)nc(N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [O-][n+]1cccc(/C(Cl)=N/OC[C@H](O)CN2CCCCC2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1N=C(C(N)=O)CCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)C=C(C)[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O[C@@H]2CCCCO2)[C@H](C)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 6 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NCN1CCOCC1)c1cnccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1NC(=O)CN1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc(Br)cc1)c1cc(Br)c(Br)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(/C=C/c1cccc(F)c1)NC1CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C[N+]([O-])=C(c2ccccc2)c2cc(Cl)ccc2N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)C1(N2CCCCC2)CCN(CCC2(c3ccc(Cl)c(Cl)c3)CN(C(=O)c3ccccc3)CCO2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)c1cccc3ccc4cccc2c4c31 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 5 rings containing 5 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-AhR, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C(/CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN1CCC[C@@H]2Cc3n[nH]cc3C[C@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)SC[C@@H](Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C2CC2)nc(Nc2ccccc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CON(Cc2ccccc2Cl)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NCC2(CCN(CCc3ccccc3)CC2)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1c(N2CCOCC2)cnn(C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCc3cc(OC)c(OC)cc3C2Cc2ccc(OC)c(OC)c2)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings containing 4 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cc(C(c2ccc(OCC3CO3)cc2)c2ccc(OCC3CO3)cc2)ccc1OCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 6 rings containing 3 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CCCC(C)(C)C12CCC(C)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)[C@@H]1CCC2=CC(=O)C[C@@H](C)[C@]2(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)[C@@H]1CCC2=CCC[C@@H](C)[C@]2(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 7 rings containing 5 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1=CCCC=CCCC=CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2sc(SN(C3CCCCC3)C3CCCCC3)nc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCN1CCc2nc(N)sc2CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC1=CC=C2[C@H]3Cc4ccc(OC)c5c4[C@@]2(CCN3C)[C@H]1O5 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c2cc(C(F)(F)F)c(N3CCOCC3)cc2n(CP(=O)(O)O)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)[C@@H](NC(=O)c2cc3ccccc3[nH]2)N=C(c2ccccc2)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)OCc2ccccc2-n2cccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 6 rings containing 4 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cc2c(c(N3CCNCC3)c1)OCCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)S[C@@H]2[C@H](N)C(=O)N2[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 6 rings. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(C)C(=O)OCCOC1CC2CC1C1C=CCC21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2c(O)cccc2[C@H]([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2cc(CO)cc(O)c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N[C@H]1[C@@H](OC2C(C(=O)O)O[C@@H](OC3[C@H]4CO[C@H](O4)[C@H](NS(=O)(=O)O)[C@H]3O)[C@H](O)[C@H]2O)O[C@H](CO)[C@@H](O[C@@H]2CC(C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4OC(C(=O)O)=C[C@H](O)[C@H]4O)[C@H](O)[C@H]3NC(C)=O)[C@H](O)[C@H]2O)[C@@H]1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 7 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Cn1cnc2c(N)nc3ccccc3c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC#CCC(C)[C@H](O)/C=C/C1[C@H](O)C[C@@H]2C/C(=C\\CCCC(=O)O)C[C@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[PH]1Oc2ccccc2-c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCCCCCCCCC(=O)OCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C(O)=C([C@H]2CC[C@H](c3ccc(Cl)cc3)CC2)C(=O)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cc(-c2ccncc2)ccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cn1c(=O)sc2ccc(Cl)cc21)N1CCN(CCO)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(CC(=O)N1CCOCC1)Cc1c(Cl)cccc1NC(=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc(/C=C/c2ccc(NC(=O)c3cc(S(=O)(=O)O)c4cccnc4c3O)cc2S(=O)(=O)O)c(S(=O)(=O)O)c1)c1cc(S(=O)(=O)O)c2cccnc2c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 6 rings containing 6 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](CC=C(C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](NC)[C@H](C)O4)[C@H](C)O3)[C@@H](C)C=CC=C3CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 7 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=S)(OCC)Oc1cc(-c2ccccc2)on1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)[C@H](/C=C2\\CCSC2=O)[C@@H]1C(=O)OCc1coc(Cc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccc(N)n3CCO)CS[C@H]12)c1csc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](NCCCc1cccc(C(F)(F)F)c1)c1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1cc(O)c(Cl)c[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CCOS(=O)OC1CCCCC1Oc1ccc(C(C)(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc(O/N=C/c2cc(Br)c(O)c(Br)c2)c([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1nccnc1NS(=O)(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2CN2C(=O)c3ccccc3CN12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1CC[C@@H]2[C@@H](C)[C@H]3[C@H](C[C@H]4[C@@H]5CC=C6CC(O[C@@H]7O[C@H](CO)[C@H](O)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@H]7O[C@@H](C)[C@H](O)[C@@H](O)[C@H]7O)CC[C@]6(C)[C@H]5CC[C@]34C)N2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 9 rings. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C=CC(=O)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(CCO)CC(O)Cn1cnc2c1c(=O)n(C)c(=O)n2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(/C=C/c2ccccc2)oc(=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc2ccccc2c1C(=O)N[C@@H]1C(=O)N2[C@@H]1SC(C)(C)[C@@H]2C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@]1([C@@H]2O[C@@H]([C@H]3O[C@@](O)(CO)[C@H](C)C[C@@H]3C)C[C@@H]2C)CC[C@H]([C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(=O)O)O3)O2)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(=O)[nH]o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)ccc1c3ccccc3ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1C(=O)N=C2Nc3cccc(Cl)c3CN21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN1CCC[C@@H](c2cccc(O)c2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1cc2c(cc1Cl)N=C(CSCc1ccccc1)NS2(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1cc(CCC(=O)OCC(COC(=O)CCc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)(COC(=O)CCc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)COC(=O)CCc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)(CC)c1cc(NC(=O)c2c(OC)cccc2OC)on1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)OCOC(=O)[C@@H]1N2C(=O)C[C@H]2S(=O)(=O)C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 5 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-AhR, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2c(cc1OC)C(C(C(=O)N(CCc1ccc(OC)c(OC)c1OC)CCc1ccc(OC)c(OC)c1OC)c1ccccc1)=NCC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNc1c2c(nn1C)CCCC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(CNCCNCc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1COC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc(F)cc1F)c1cccnc1Oc1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C/C=C/c1ccccc1)Cc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC(=O)CC(C)(C)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC1=NC(=O)C(c2ccccc2)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CCC(=C(C)C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C1\\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1CN for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(CO/N=C(\\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C=C2C=C[C@@H]3C[C@@]2(O1)[C@H]1CCCCN31 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(OC)nc(NC(=O)NS(=O)(=O)c2ncccc2OCC(F)(F)F)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(OCCn2ccnc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccnc4)=CC[C@@H]32)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC=O)cn3C)cn2C)cc1C(=O)NCCC(=N)N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1coc2c1CCC(C)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2c(cc1O)CCN[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@H](COC1=O)N1[C@@H]2[C@H]2c3c(cc(C)c(OC)c3O)C[C@@H]([C@@H]1O)N2C)OCO4 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 10 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCOCCOCCOCCOCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1NCCOC1c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(C2(c3ccccc3)CC2C2=NCCN2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(C=Cc1ccccc1)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)CC[C@H]1c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC12CCC(C[N+](C)(CCC[N+](C)(C)C)C1)C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C(=O)c2ncccc2-c2cccnc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(S(=O)(=O)NCc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(S(=O)(=O)NC(=O)N[C@@H](C)Cc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)Cc1nccn1-c1ccc([N+](=O)[O-])cc1C(=O)c1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(F)(F)[C@@]1(O)CC[C@H]2[C@@H](CC(=O)[C@@H]2CCCCCCC(=O)O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C(=O)Nc2ccc(O)c(Cl)c2Cl)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1[C@@H]2CC[C@H]1C[C@@H](OC1c3ccccc3CCc3ccccc31)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 5 rings containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCc1nc(-c2ccccc2)no1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1c[nH]cc1-c1cccc2c1OC(F)(F)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER-LBD) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\\CCC=C(C)C)C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1c(O)cc2c(c1O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1OC2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ncc(CSSCc2cnc(C)c(O)c2CO)c(CO)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc[nH]c1CN1CCc2c(c3ccccc3n2C)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1[C@@H]2CCC[C@H]1C[C@@H](NC(=O)c1nn(C)c3ccccc13)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S1(=O)OCC2C(CO1)C1(Cl)C(Cl)=C(Cl)C2(Cl)C1(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings. MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)C=C[C@]2(C)OC2C1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). MODERATE-RISK: reactive aldehyde. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(C=Cc1ccc(O)c(O)c1)O[C@@H]1C[C@@](OC(=O)C=Cc2ccc(O)c(O)c2)(C(=O)O)C[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c(=O)c2ccccc2o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC1=C(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(=O)O)C(CCC(=O)O)=C4C)c(C)c3C=C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(N=Nc2ccccc2)c(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=C(CCOP(=O)(O)O)SC(=O)c1ccccc1)N(C=O)Cc1cnc(C)nc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2C(=O)N1SC1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1CCC[C@H](O)CCCCCc2cc(O)cc(O)c2C(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC1=C(Cl)C1(Cl)Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCN1CC1)OCC(CO)(COC(=O)CCN1CC1)COC(=O)CCN1CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 5 rings containing 4 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 5 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1C(=O)O[C@@H]2CCN3CC=C(COC(=O)[C@](C)(O)[C@]1(C)O)[C@H]23 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@H]1C=CO[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(c1cccc2cnccc12)N1CCCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)CCNC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCCCNC(=N)N)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1cnc[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 6 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 5 rings containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CC(OC(=O)CCCCCCCCC(=O)OC2CC(C)(C)NC(C)(C)C2)CC(C)(C)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(=O)OCc1cccc(OC(=O)[C@@H]2N3C(=O)[C@@H](NC(=O)Cc4ccccc4)[C@H]3SC2(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCCOC(=O)C(C)(C)Oc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1oc(-c2ccccc2)nc1CCC(=O)c1ccc(CC2SC(=O)NC2=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCCCN1CCCOC(=O)c1ccc(OC2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(CCCOc2c(C)cc(-c3noc(C(F)(F)F)n3)cc2C)on1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC(OC(=O)c2cccnc2Nc2cccc(C(F)(F)F)c2)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C1(C)CC2=C(CCCC2(C)C)CC1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CCC[C@@H](C)[C@H]1CC(=O)C2=C3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#C[C@@H]1CC(F)(F)CN1C(=O)CNC1CC2CCC(C1)N2c1ncccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  }
]